<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns="http://purl.org/rss/1.0/">
<channel rdf:about="http://www.nature.com/nature/current_issue/rss">
<title>Nature AOP</title>
<description>Nature is a weekly international journal publishing the finest peer-reviewed research in all fields of science and technology on the basis of its originality, importance, interdisciplinary interest, timeliness, accessibility, elegance and surprising conclusions. Nature also provides rapid, authoritative, insightful and arresting news and interpretation of topical and coming trends affecting science, scientists and the wider public.</description>
<link>http://www.nature.com/nature/current_issue/</link>
<dc:publisher>Nature Publishing Group</dc:publisher>
<dc:language>en</dc:language>
<dc:rights>&#169;  Nature Publishing Group</dc:rights>
<prism:publicationName>Nature</prism:publicationName>
<prism:issn>0028-0836</prism:issn>
<prism:eIssn>1476-4679</prism:eIssn>
<prism:copyright>&#169;  Nature Publishing Group</prism:copyright>
<prism:rightsAgent>permissions@nature.com</prism:rightsAgent>
<image rdf:resource="http://www.nature.com/includes/rj_globnavimages/nature_logo.gif"/>
<items>
<rdf:Seq>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06953"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06969"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06956"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06957"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature07016"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06951"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06719"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06963"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature07021"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature07005"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature07007"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06923"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06947"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06933"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06938"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06943"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature07015"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06955"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06910"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06891"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature07006"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06944"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06902"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06892"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06907"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06909"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06906"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06883"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06903"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06890"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06875"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06905"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06894"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06901"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06945"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06934"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06928"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06904"/>
<rdf:li rdf:resource="http://dx.doi.org/10.1038/nature06908"/>
</rdf:Seq>
</items>
</channel>
<image rdf:about="http://www.nature.com/includes/rj_globnavimages/nature_logo.gif">
<title>Nature AOP</title>
<url>http://www.nature.com/includes/rj_globnavimages/nature_logo.gif</url>
<link>http://www.nature.com/nature/</link>
</image>
<item rdf:about="http://dx.doi.org/10.1038/nature06953">
<title>A two-tiered mechanism for stabilization and immobilization of E-cadherin</title>
<link>http://dx.doi.org/10.1038/nature06953</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>A two-tiered mechanism for stabilization and immobilization of E-cadherin</b>
</p>
<p>Nature advance online publication 14 May 2008. <a href="http://dx.doi.org/10.1038/nature06953">doi:10.1038/nature06953</a>
</p>
<p>Authors: Matthieu Cavey, Matteo Rauzi, Pierre-Fran&#231;ois Lenne
&amp; Thomas Lecuit</p>
]]></content:encoded>
<dc:title>A two-tiered mechanism for stabilization and immobilization of E-cadherin</dc:title>
<dc:creator>Matthieu Cavey</dc:creator>
<dc:creator>Matteo Rauzi</dc:creator>
<dc:creator>Pierre-Fran&#231;ois Lenne</dc:creator>
<dc:creator>Thomas Lecuit</dc:creator>
<dc:identifier>doi:10.1038/nature06953</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-05-14</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-05-14</prism:publicationDate>
<prism:section>Article</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature06969">
<title>A myocardial lineage derives from Tbx18 epicardial cells</title>
<link>http://dx.doi.org/10.1038/nature06969</link>
<description>Understanding the origins and roles of cardiac progenitor cells is important for elucidating the pathogenesis of congenital and acquired heart diseases. Moreover, manipulation of cardiac myocyte progenitors has potential for cell-based repair strategies for various myocardial disorders. Here we report the identification in mouse of a previously unknown cardiac myocyte lineage that derives from the proepicardial organ. These progenitor cells, which express the T-box transcription factor Tbx18, migrate onto the outer cardiac surface to form the epicardium, and then make a substantial contribution to myocytes in the ventricular septum and the atrial and ventricular walls. Tbx18-expressing cardiac progenitors also give rise to cardiac fibroblasts and coronary smooth muscle cells. The pluripotency of Tbx18 proepicardial cells provides a theoretical framework for applying these progenitors to effect cardiac repair and regeneration.</description>
<content:encoded><![CDATA[

<p>
<b>A myocardial lineage derives from Tbx18 epicardial cells</b>
</p>
<p>Nature advance online publication 14 May 2008. <a href="http://dx.doi.org/10.1038/nature06969">doi:10.1038/nature06969</a>
</p>
<p>Authors: Chen-Leng Cai, Jody C. Martin, Yunfu Sun, Li Cui, Lianchun Wang, Kunfu Ouyang, Lei Yang, Lei Bu, Xingqun Liang, Xiaoxue Zhang, William B. Stallcup, Christopher P. Denton, Andrew McCulloch, Ju Chen
&amp; Sylvia M. Evans</p>
<p>Understanding the origins and roles of cardiac progenitor cells is important for elucidating the pathogenesis of congenital and acquired heart diseases. Moreover, manipulation of cardiac myocyte progenitors has potential for cell-based repair strategies for various myocardial disorders. Here we report the identification in mouse of a previously unknown cardiac myocyte lineage that derives from the proepicardial organ. These progenitor cells, which express the T-box transcription factor Tbx18, migrate onto the outer cardiac surface to form the epicardium, and then make a substantial contribution to myocytes in the ventricular septum and the atrial and ventricular walls. Tbx18-expressing cardiac progenitors also give rise to cardiac fibroblasts and coronary smooth muscle cells. The pluripotency of Tbx18 proepicardial cells provides a theoretical framework for applying these progenitors to effect cardiac repair and regeneration.</p>
]]></content:encoded>
<dc:title>A myocardial lineage derives from Tbx18 epicardial cells</dc:title>
<dc:creator>Chen-Leng Cai</dc:creator>
<dc:creator>Jody C. Martin</dc:creator>
<dc:creator>Yunfu Sun</dc:creator>
<dc:creator>Li Cui</dc:creator>
<dc:creator>Lianchun Wang</dc:creator>
<dc:creator>Kunfu Ouyang</dc:creator>
<dc:creator>Lei Yang</dc:creator>
<dc:creator>Lei Bu</dc:creator>
<dc:creator>Xingqun Liang</dc:creator>
<dc:creator>Xiaoxue Zhang</dc:creator>
<dc:creator>William B. Stallcup</dc:creator>
<dc:creator>Christopher P. Denton</dc:creator>
<dc:creator>Andrew McCulloch</dc:creator>
<dc:creator>Ju Chen</dc:creator>
<dc:creator>Sylvia M. Evans</dc:creator>
<dc:identifier>doi:10.1038/nature06969</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-05-14</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-05-14</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature06956">
<title>Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants</title>
<link>http://dx.doi.org/10.1038/nature06956</link>
<description>The potential impact of pandemic influenza makes effective measures to limit the spread and morbidity of virus infection a public health priority. Antiviral drugs are seen as essential requirements for control of initial influenza outbreaks caused by a new virus, and in pre-pandemic plans there is a heavy reliance on drug stockpiles. The principal target for these drugs is a virus surface glycoprotein, neuraminidase, which facilitates the release of nascent virus and thus the spread of infection. Oseltamivir (Tamiflu) and zanamivir (Relenza) are two currently used neuraminidase inhibitors that were developed using knowledge of the enzyme structure. It has been proposed that the closer such inhibitors resemble the natural substrate, the less likely they are to select drug-resistant mutant viruses that retain viability. However, there have been reports of drug-resistant mutant selection in vitro and from infected humans. We report here the enzymatic properties and crystal structures of neuraminidase mutants from H5N1-infected patients that explain the molecular basis of resistance. Our results show that these mutants are resistant to oseltamivir but still strongly inhibited by zanamivir owing to an altered hydrophobic pocket in the active site of the enzyme required for oseltamivir binding. Together with recent reports of the viability and pathogenesis of H5N1 (ref. 7) and H1N1 (ref. 8) viruses with neuraminidases carrying these mutations, our results indicate that it would be prudent for pandemic stockpiles of oseltamivir to be augmented by additional antiviral drugs, including zanamivir.</description>
<content:encoded><![CDATA[

<p>
<b>Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants</b>
</p>
<p>Nature advance online publication 14 May 2008. <a href="http://dx.doi.org/10.1038/nature06956">doi:10.1038/nature06956</a>
</p>
<p>Authors: Patrick J. Collins, Lesley F. Haire, Yi Pu Lin, Junfeng Liu, Rupert J. Russell, Philip A. Walker, John J. Skehel, Stephen R. Martin, Alan J. Hay
&amp; Steven J. Gamblin</p>
<p>The potential impact of pandemic influenza makes effective measures to limit the spread and morbidity of virus infection a public health priority. Antiviral drugs are seen as essential requirements for control of initial influenza outbreaks caused by a new virus, and in pre-pandemic plans there is a heavy reliance on drug stockpiles. The principal target for these drugs is a virus surface glycoprotein, neuraminidase, which facilitates the release of nascent virus and thus the spread of infection. Oseltamivir (Tamiflu) and zanamivir (Relenza) are two currently used neuraminidase inhibitors that were developed using knowledge of the enzyme structure. It has been proposed that the closer such inhibitors resemble the natural substrate, the less likely they are to select drug-resistant mutant viruses that retain viability. However, there have been reports of drug-resistant mutant selection in vitro and from infected humans. We report here the enzymatic properties and crystal structures of neuraminidase mutants from H5N1-infected patients that explain the molecular basis of resistance. Our results show that these mutants are resistant to oseltamivir but still strongly inhibited by zanamivir owing to an altered hydrophobic pocket in the active site of the enzyme required for oseltamivir binding. Together with recent reports of the viability and pathogenesis of H5N1 (ref. 7) and H1N1 (ref. 8) viruses with neuraminidases carrying these mutations, our results indicate that it would be prudent for pandemic stockpiles of oseltamivir to be augmented by additional antiviral drugs, including zanamivir.</p>
]]></content:encoded>
<dc:title>Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants</dc:title>
<dc:creator>Patrick J. Collins</dc:creator>
<dc:creator>Lesley F. Haire</dc:creator>
<dc:creator>Yi Pu Lin</dc:creator>
<dc:creator>Junfeng Liu</dc:creator>
<dc:creator>Rupert J. Russell</dc:creator>
<dc:creator>Philip A. Walker</dc:creator>
<dc:creator>John J. Skehel</dc:creator>
<dc:creator>Stephen R. Martin</dc:creator>
<dc:creator>Alan J. Hay</dc:creator>
<dc:creator>Steven J. Gamblin</dc:creator>
<dc:identifier>doi:10.1038/nature06956</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-05-14</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-05-14</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature06957">
<title>Hippocampus-independent phase precession in entorhinal grid cells</title>
<link>http://dx.doi.org/10.1038/nature06957</link>
<description>Theta-phase precession in hippocampal place cells is one of the best-studied experimental models of temporal coding in the brain. Theta-phase precession is a change in spike timing in which the place cell fires at progressively earlier phases of the extracellular theta rhythm as the animal crosses the spatially restricted firing field of the neuron. Within individual theta cycles, this phase advance results in a compressed replication of the firing sequence of consecutively activated place cells along the animal&#8217;s trajectory, at a timescale short enough to enable spike-time-dependent plasticity between neurons in different parts of the sequence. The neuronal circuitry required for phase precession has not yet been established. The fact that phase precession can be seen in hippocampal output stuctures such as the prefrontal cortex suggests either that efferent structures inherit the precession from the hippocampus or that it is generated locally in those structures. Here we show that phase precession is expressed independently of the hippocampus in spatially modulated grid cells in layer II of medial entorhinal cortex, one synapse upstream of the hippocampus. Phase precession is apparent in nearly all principal cells in layer II but only sparsely in layer III. The precession in layer II is not blocked by inactivation of the hippocampus, suggesting that the phase advance is generated in the grid cell network. The results point to possible mechanisms for grid formation and raise the possibility that hippocampal phase precession is inherited from entorhinal cortex.</description>
<content:encoded><![CDATA[

<p>
<b>Hippocampus-independent phase precession in entorhinal grid cells</b>
</p>
<p>Nature advance online publication 14 May 2008. <a href="http://dx.doi.org/10.1038/nature06957">doi:10.1038/nature06957</a>
</p>
<p>Authors: Torkel Hafting, Marianne Fyhn, Tora Bonnevie, May-Britt Moser
&amp; Edvard I. Moser</p>
<p>Theta-phase precession in hippocampal place cells is one of the best-studied experimental models of temporal coding in the brain. Theta-phase precession is a change in spike timing in which the place cell fires at progressively earlier phases of the extracellular theta rhythm as the animal crosses the spatially restricted firing field of the neuron. Within individual theta cycles, this phase advance results in a compressed replication of the firing sequence of consecutively activated place cells along the animal&#8217;s trajectory, at a timescale short enough to enable spike-time-dependent plasticity between neurons in different parts of the sequence. The neuronal circuitry required for phase precession has not yet been established. The fact that phase precession can be seen in hippocampal output stuctures such as the prefrontal cortex suggests either that efferent structures inherit the precession from the hippocampus or that it is generated locally in those structures. Here we show that phase precession is expressed independently of the hippocampus in spatially modulated grid cells in layer II of medial entorhinal cortex, one synapse upstream of the hippocampus. Phase precession is apparent in nearly all principal cells in layer II but only sparsely in layer III. The precession in layer II is not blocked by inactivation of the hippocampus, suggesting that the phase advance is generated in the grid cell network. The results point to possible mechanisms for grid formation and raise the possibility that hippocampal phase precession is inherited from entorhinal cortex.</p>
]]></content:encoded>
<dc:title>Hippocampus-independent phase precession in entorhinal grid cells</dc:title>
<dc:creator>Torkel Hafting</dc:creator>
<dc:creator>Marianne Fyhn</dc:creator>
<dc:creator>Tora Bonnevie</dc:creator>
<dc:creator>May-Britt Moser</dc:creator>
<dc:creator>Edvard I. Moser</dc:creator>
<dc:identifier>doi:10.1038/nature06957</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-05-14</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-05-14</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature07016">
<title>PML targeting eradicates quiescent leukaemia-initiating cells</title>
<link>http://dx.doi.org/10.1038/nature07016</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>PML targeting eradicates quiescent leukaemia-initiating cells</b>
</p>
<p>Nature advance online publication 11 May 2008. <a href="http://dx.doi.org/10.1038/nature07016">doi:10.1038/nature07016</a>
</p>
<p>Authors: Keisuke Ito, Rosa Bernardi, Alessandro Morotti, Sahoko Matsuoka, Giuseppe Saglio, Yasuo Ikeda, Jacalyn Rosenblatt, David E. Avigan, Julie Teruya-Feldstein
&amp; Pier Paolo Pandolfi</p>
]]></content:encoded>
<dc:title>PML targeting eradicates quiescent leukaemia-initiating cells</dc:title>
<dc:creator>Keisuke Ito</dc:creator>
<dc:creator>Rosa Bernardi</dc:creator>
<dc:creator>Alessandro Morotti</dc:creator>
<dc:creator>Sahoko Matsuoka</dc:creator>
<dc:creator>Giuseppe Saglio</dc:creator>
<dc:creator>Yasuo Ikeda</dc:creator>
<dc:creator>Jacalyn Rosenblatt</dc:creator>
<dc:creator>David E. Avigan</dc:creator>
<dc:creator>Julie Teruya-Feldstein</dc:creator>
<dc:creator>Pier Paolo Pandolfi</dc:creator>
<dc:identifier>doi:10.1038/nature07016</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-05-11</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-05-11</prism:publicationDate>
<prism:section>Article</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature06951">
<title>Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia</title>
<link>http://dx.doi.org/10.1038/nature06951</link>
<description>Despite intense investigation, mechanisms that facilitate the emergence of the pre-eclampsia phenotype in women are still unknown. Placental hypoxia, hypertension, proteinuria and oedema are the principal clinical features of this disease. It is speculated that hypoxia-driven disruption of the angiogenic balance involving vascular endothelial growth factor (VEGF)/placenta-derived growth factor (PLGF) and soluble Fms-like tyrosine kinase-1 (sFLT-1, the soluble form of VEGF receptor 1) might contribute to some of the maternal symptoms of pre-eclampsia. However, pre-eclampsia does not develop in all women with high sFLT-1 or low PLGF levels, and it also occurs in some women with low sFLT-1 and high PLGF levels. Moreover, recent experiments strongly suggest that several soluble factors affecting the vasculature are probably elevated because of placental hypoxia in the pre-eclamptic women, indicating that upstream molecular defect(s) may contribute to pre-eclampsia. Here we show that pregnant mice deficient in catechol-O-methyltransferase (COMT) show a pre-eclampsia-like phenotype resulting from an absence of 2-methoxyoestradiol (2-ME), a natural metabolite of oestradiol that is elevated during the third trimester of normal human pregnancy. 2-ME ameliorates all pre-eclampsia-like features without toxicity in the Comt-/- pregnant mice and suppresses placental hypoxia, hypoxia-inducible factor-1&#945; expression and sFLT-1 elevation. The levels of COMT and 2-ME are significantly lower in women with severe pre-eclampsia. Our studies identify a genetic mouse model for pre-eclampsia and suggest that 2-ME may have utility as a plasma and urine diagnostic marker for this disease, and may also serve as a therapeutic supplement to prevent or treat this disorder.</description>
<content:encoded><![CDATA[

<p>
<b>Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia</b>
</p>
<p>Nature advance online publication 11 May 2008. <a href="http://dx.doi.org/10.1038/nature06951">doi:10.1038/nature06951</a>
</p>
<p>Authors: Keizo Kanasaki, Kristin Palmsten, Hikaru Sugimoto, Shakil Ahmad, Yuki Hamano, Liang Xie, Samuel Parry, Hellmut G. Augustin, Vincent H. Gattone, Judah Folkman, Jerome F. Strauss
&amp; Raghu Kalluri</p>
<p>Despite intense investigation, mechanisms that facilitate the emergence of the pre-eclampsia phenotype in women are still unknown. Placental hypoxia, hypertension, proteinuria and oedema are the principal clinical features of this disease. It is speculated that hypoxia-driven disruption of the angiogenic balance involving vascular endothelial growth factor (VEGF)/placenta-derived growth factor (PLGF) and soluble Fms-like tyrosine kinase-1 (sFLT-1, the soluble form of VEGF receptor 1) might contribute to some of the maternal symptoms of pre-eclampsia. However, pre-eclampsia does not develop in all women with high sFLT-1 or low PLGF levels, and it also occurs in some women with low sFLT-1 and high PLGF levels. Moreover, recent experiments strongly suggest that several soluble factors affecting the vasculature are probably elevated because of placental hypoxia in the pre-eclamptic women, indicating that upstream molecular defect(s) may contribute to pre-eclampsia. Here we show that pregnant mice deficient in catechol-O-methyltransferase (COMT) show a pre-eclampsia-like phenotype resulting from an absence of 2-methoxyoestradiol (2-ME), a natural metabolite of oestradiol that is elevated during the third trimester of normal human pregnancy. 2-ME ameliorates all pre-eclampsia-like features without toxicity in the Comt-/- pregnant mice and suppresses placental hypoxia, hypoxia-inducible factor-1&#945; expression and sFLT-1 elevation. The levels of COMT and 2-ME are significantly lower in women with severe pre-eclampsia. Our studies identify a genetic mouse model for pre-eclampsia and suggest that 2-ME may have utility as a plasma and urine diagnostic marker for this disease, and may also serve as a therapeutic supplement to prevent or treat this disorder.</p>
]]></content:encoded>
<dc:title>Deficiency in catechol-O-methyltransferase and 2-methoxyoestradiol is associated with pre-eclampsia</dc:title>
<dc:creator>Keizo Kanasaki</dc:creator>
<dc:creator>Kristin Palmsten</dc:creator>
<dc:creator>Hikaru Sugimoto</dc:creator>
<dc:creator>Shakil Ahmad</dc:creator>
<dc:creator>Yuki Hamano</dc:creator>
<dc:creator>Liang Xie</dc:creator>
<dc:creator>Samuel Parry</dc:creator>
<dc:creator>Hellmut G. Augustin</dc:creator>
<dc:creator>Vincent H. Gattone</dc:creator>
<dc:creator>Judah Folkman</dc:creator>
<dc:creator>Jerome F. Strauss</dc:creator>
<dc:creator>Raghu Kalluri</dc:creator>
<dc:identifier>doi:10.1038/nature06951</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-05-11</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-05-11</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature06719">
<title>Ultrasonic frogs show hyperacute phonotaxis to female courtship calls</title>
<link>http://dx.doi.org/10.1038/nature06719</link>
<description>Sound communication plays a vital role in frog reproduction, in which vocal advertisement is generally the domain of males. Females are typically silent, but in a few anuran species they can produce a feeble reciprocal call or rapping sounds during courtship. Males of concave-eared torrent frogs (Odorrana tormota) have demonstrated ultrasonic communication capacity. Although females of O. tormota have an unusually well-developed vocal production system, it is unclear whether or not they produce calls or are only passive partners in a communication system dominated by males. Here we show that before ovulation, gravid females of O. tormota emit calls that are distinct from males&#8217; advertisement calls, having higher fundamental frequencies and harmonics and shorter call duration. In the field and in a quiet, darkened indoor arena, these female calls evoke vocalizations and extraordinarily precise positive phonotaxis (a localization error of </description>
<content:encoded><![CDATA[

<p>
<b>Ultrasonic frogs show hyperacute phonotaxis to female courtship calls</b>
</p>
<p>Nature advance online publication 11 May 2008. <a href="http://dx.doi.org/10.1038/nature06719">doi:10.1038/nature06719</a>
</p>
<p>Authors: Jun-Xian Shen, Albert S. Feng, Zhi-Min Xu, Zu-Lin Yu, Victoria S. Arch, Xin-Jian Yu
&amp; Peter M. Narins</p>
<p>Sound communication plays a vital role in frog reproduction, in which vocal advertisement is generally the domain of males. Females are typically silent, but in a few anuran species they can produce a feeble reciprocal call or rapping sounds during courtship. Males of concave-eared torrent frogs (Odorrana tormota) have demonstrated ultrasonic communication capacity. Although females of O. tormota have an unusually well-developed vocal production system, it is unclear whether or not they produce calls or are only passive partners in a communication system dominated by males. Here we show that before ovulation, gravid females of O. tormota emit calls that are distinct from males&#8217; advertisement calls, having higher fundamental frequencies and harmonics and shorter call duration. In the field and in a quiet, darkened indoor arena, these female calls evoke vocalizations and extraordinarily precise positive phonotaxis (a localization error of </p>
]]></content:encoded>
<dc:title>Ultrasonic frogs show hyperacute phonotaxis to female courtship calls</dc:title>
<dc:creator>Jun-Xian Shen</dc:creator>
<dc:creator>Albert S. Feng</dc:creator>
<dc:creator>Zhi-Min Xu</dc:creator>
<dc:creator>Zu-Lin Yu</dc:creator>
<dc:creator>Victoria S. Arch</dc:creator>
<dc:creator>Xin-Jian Yu</dc:creator>
<dc:creator>Peter M. Narins</dc:creator>
<dc:identifier>doi:10.1038/nature06719</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-05-11</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-05-11</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature06963">
<title>Rapid strengthening of thalamo-amygdala synapses mediates cue&#8211;reward learning</title>
<link>http://dx.doi.org/10.1038/nature06963</link>
<description>What neural changes underlie individual differences in goal-directed learning? The lateral amygdala (LA) is important for assigning emotional and motivational significance to discrete environmental cues, including those that signal rewarding events. Recognizing that a cue predicts a reward enhances an animal&#8217;s ability to acquire that reward; however, the cellular and synaptic mechanisms that underlie cue&#8211;reward learning are unclear. Here we show that marked changes in both cue-induced neuronal firing and input-specific synaptic strength occur with the successful acquisition of a cue&#8211;reward association within a single training session. We performed both in vivo and ex vivo electrophysiological recordings in the LA of rats trained to self-administer sucrose. We observed that reward-learning success increased in proportion to the number of amygdala neurons that responded phasically to a reward-predictive cue. Furthermore, cue&#8211;reward learning induced an AMPA (&#945;-amino-3-hydroxy-5-methyl-isoxazole propionic acid)-receptor-mediated increase in the strength of thalamic, but not cortical, synapses in the LA that was apparent immediately after the first training session. The level of learning attained by individual subjects was highly correlated with the degree of synaptic strength enhancement. Importantly, intra-LA NMDA (N-methyl-d-aspartate)-receptor blockade impaired reward-learning performance and attenuated the associated increase in synaptic strength. These findings provide evidence of a connection between LA synaptic plasticity and cue&#8211;reward learning, potentially representing a key mechanism underlying goal-directed behaviour.</description>
<content:encoded><![CDATA[

<p>
<b>Rapid strengthening of thalamo-amygdala synapses mediates cue&#8211;reward learning</b>
</p>
<p>Nature advance online publication 11 May 2008. <a href="http://dx.doi.org/10.1038/nature06963">doi:10.1038/nature06963</a>
</p>
<p>Authors: Kay M. Tye, Garret D. Stuber, Bram de Ridder, Antonello Bonci
&amp; Patricia H. Janak</p>
<p>What neural changes underlie individual differences in goal-directed learning? The lateral amygdala (LA) is important for assigning emotional and motivational significance to discrete environmental cues, including those that signal rewarding events. Recognizing that a cue predicts a reward enhances an animal&#8217;s ability to acquire that reward; however, the cellular and synaptic mechanisms that underlie cue&#8211;reward learning are unclear. Here we show that marked changes in both cue-induced neuronal firing and input-specific synaptic strength occur with the successful acquisition of a cue&#8211;reward association within a single training session. We performed both in vivo and ex vivo electrophysiological recordings in the LA of rats trained to self-administer sucrose. We observed that reward-learning success increased in proportion to the number of amygdala neurons that responded phasically to a reward-predictive cue. Furthermore, cue&#8211;reward learning induced an AMPA (&#945;-amino-3-hydroxy-5-methyl-isoxazole propionic acid)-receptor-mediated increase in the strength of thalamic, but not cortical, synapses in the LA that was apparent immediately after the first training session. The level of learning attained by individual subjects was highly correlated with the degree of synaptic strength enhancement. Importantly, intra-LA NMDA (N-methyl-d-aspartate)-receptor blockade impaired reward-learning performance and attenuated the associated increase in synaptic strength. These findings provide evidence of a connection between LA synaptic plasticity and cue&#8211;reward learning, potentially representing a key mechanism underlying goal-directed behaviour.</p>
]]></content:encoded>
<dc:title>Rapid strengthening of thalamo-amygdala synapses mediates cue&#8211;reward learning</dc:title>
<dc:creator>Kay M. Tye</dc:creator>
<dc:creator>Garret D. Stuber</dc:creator>
<dc:creator>Bram de Ridder</dc:creator>
<dc:creator>Antonello Bonci</dc:creator>
<dc:creator>Patricia H. Janak</dc:creator>
<dc:identifier>doi:10.1038/nature06963</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-05-11</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-05-11</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature07021">
<title>IL-21 and TGF-&#946; are required for differentiation of human TH17 cells</title>
<link>http://dx.doi.org/10.1038/nature07021</link>
<description>The recent discovery of CD4+ T cells characterized by secretion of interleukin (IL)-17 (TH17 cells) and the naturally occurring regulatory FOXP3+ CD4 T cell (nTreg) has had a major impact on our understanding of immune processes not readily explained by the TH1/TH2 paradigm. TH17 and nTreg cells have been implicated in the pathogenesis of human autoimmune diseases, including multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease and psoriasis. Our recent data and the work of others demonstrated that transforming growth factor-&#946; (TGF-&#946;) and IL-6 are responsible for the differentiation of naive mouse T cells into TH17 cells, and it has been proposed that IL-23 may have a critical role in stabilization of the TH17 phenotype. A second pathway has been discovered in which a combination of TGF-&#946; and IL-21 is capable of inducing differentiation of mouse TH17 cells in the absence of IL-6 (refs 6&#8211;8). However, TGF-&#946; and IL-6 are not capable of differentiating human TH17 cells and it has been suggested that TGF-&#946; may in fact suppress the generation of human TH17 cells. Instead, it has been recently shown that the cytokines IL-1&#946;, IL-6 and IL-23 are capable of driving IL-17 secretion in short-term CD4+ T cell lines isolated from human peripheral blood, although the factors required for differentiation of naive human CD4 to TH17 cells are still unknown. Here we confirm that whereas IL-1&#946; and IL-6 induce IL-17A secretion from human central memory CD4+ T cells, TGF-&#946; and IL-21 uniquely promote the differentiation of human naive CD4+ T cells into TH17 cells accompanied by expression of the transcription factor RORC2. These data will allow the investigation of this new population of TH17 cells in human inflammatory disease.</description>
<content:encoded><![CDATA[

<p>
<b>IL-21 and TGF-&#946; are required for differentiation of human TH17 cells</b>
</p>
<p>Nature advance online publication 11 May 2008. <a href="http://dx.doi.org/10.1038/nature07021">doi:10.1038/nature07021</a>
</p>
<p>Authors: Li Yang, David E. Anderson, Clare Baecher-Allan, William D. Hastings, Estelle Bettelli, Mohamed Oukka, Vijay K. Kuchroo
&amp; David A. Hafler</p>
<p>The recent discovery of CD4+ T cells characterized by secretion of interleukin (IL)-17 (TH17 cells) and the naturally occurring regulatory FOXP3+ CD4 T cell (nTreg) has had a major impact on our understanding of immune processes not readily explained by the TH1/TH2 paradigm. TH17 and nTreg cells have been implicated in the pathogenesis of human autoimmune diseases, including multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease and psoriasis. Our recent data and the work of others demonstrated that transforming growth factor-&#946; (TGF-&#946;) and IL-6 are responsible for the differentiation of naive mouse T cells into TH17 cells, and it has been proposed that IL-23 may have a critical role in stabilization of the TH17 phenotype. A second pathway has been discovered in which a combination of TGF-&#946; and IL-21 is capable of inducing differentiation of mouse TH17 cells in the absence of IL-6 (refs 6&#8211;8). However, TGF-&#946; and IL-6 are not capable of differentiating human TH17 cells and it has been suggested that TGF-&#946; may in fact suppress the generation of human TH17 cells. Instead, it has been recently shown that the cytokines IL-1&#946;, IL-6 and IL-23 are capable of driving IL-17 secretion in short-term CD4+ T cell lines isolated from human peripheral blood, although the factors required for differentiation of naive human CD4 to TH17 cells are still unknown. Here we confirm that whereas IL-1&#946; and IL-6 induce IL-17A secretion from human central memory CD4+ T cells, TGF-&#946; and IL-21 uniquely promote the differentiation of human naive CD4+ T cells into TH17 cells accompanied by expression of the transcription factor RORC2. These data will allow the investigation of this new population of TH17 cells in human inflammatory disease.</p>
]]></content:encoded>
<dc:title>IL-21 and TGF-&#946; are required for differentiation of human TH17 cells</dc:title>
<dc:creator>Li Yang</dc:creator>
<dc:creator>David E. Anderson</dc:creator>
<dc:creator>Clare Baecher-Allan</dc:creator>
<dc:creator>William D. Hastings</dc:creator>
<dc:creator>Estelle Bettelli</dc:creator>
<dc:creator>Mohamed Oukka</dc:creator>
<dc:creator>Vijay K. Kuchroo</dc:creator>
<dc:creator>David A. Hafler</dc:creator>
<dc:identifier>doi:10.1038/nature07021</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-05-11</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-05-11</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature07005">
<title>The branching programme of mouse lung development</title>
<link>http://dx.doi.org/10.1038/nature07005</link>
<description/>
<content:encoded><![CDATA[

<p>
<b>The branching programme of mouse lung development</b>
</p>
<p>Nature advance online publication 07 May 2008. <a href="http://dx.doi.org/10.1038/nature07005">doi:10.1038/nature07005</a>
</p>
<p>Authors: Ross J. Metzger, Ophir D. Klein, Gail R. Martin
&amp; Mark A. Krasnow</p>
]]></content:encoded>
<dc:title>The branching programme of mouse lung development</dc:title>
<dc:creator>Ross J. Metzger</dc:creator>
<dc:creator>Ophir D. Klein</dc:creator>
<dc:creator>Gail R. Martin</dc:creator>
<dc:creator>Mark A. Krasnow</dc:creator>
<dc:identifier>doi:10.1038/nature07005</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-05-07</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-05-07</prism:publicationDate>
<prism:section>Article</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature07007">
<title>An endogenous small interfering RNA pathway in Drosophila</title>
<link>http://dx.doi.org/10.1038/nature07007</link>
<description>Drosophila endogenous small RNAs are categorized according to their mechanisms of biogenesis and the Argonaute protein to which they bind. MicroRNAs are a class of ubiquitously expressed RNAs of &#8764;22 nucleotides in length, which arise from structured precursors through the action of Drosha&#8211;Pasha and Dicer-1&#8211;Loquacious complexes. These join Argonaute-1 to regulate gene expression. A second endogenous small RNA class, the Piwi-interacting RNAs, bind Piwi proteins and suppress transposons. Piwi-interacting RNAs are restricted to the gonad, and at least a subset of these arises by Piwi-catalysed cleavage of single-stranded RNAs. Here we show that Drosophila generates a third small RNA class, endogenous small interfering RNAs, in both gonadal and somatic tissues. Production of these RNAs requires Dicer-2, but a subset depends preferentially on Loquacious rather than the canonical Dicer-2 partner, R2D2 (ref. 14). Endogenous small interfering RNAs arise both from convergent transcription units and from structured genomic loci in a tissue-specific fashion. They predominantly join Argonaute-2 and have the capacity, as a class, to target both protein-coding genes and mobile elements. These observations expand the repertoire of small RNAs in Drosophila, adding a class that blurs distinctions based on known biogenesis mechanisms and functional roles.</description>
<content:encoded><![CDATA[

<p>
<b>An endogenous small interfering RNA pathway in Drosophila</b>
</p>
<p>Nature advance online publication 07 May 2008. <a href="http://dx.doi.org/10.1038/nature07007">doi:10.1038/nature07007</a>
</p>
<p>Authors: Benjamin Czech, Colin D. Malone, Rui Zhou, Alexander Stark, Catherine Schlingeheyde, Monica Dus, Norbert Perrimon, Manolis Kellis, James A. Wohlschlegel, Ravi Sachidanandam, Gregory J. Hannon
&amp; Julius Brennecke</p>
<p>Drosophila endogenous small RNAs are categorized according to their mechanisms of biogenesis and the Argonaute protein to which they bind. MicroRNAs are a class of ubiquitously expressed RNAs of &#8764;22 nucleotides in length, which arise from structured precursors through the action of Drosha&#8211;Pasha and Dicer-1&#8211;Loquacious complexes. These join Argonaute-1 to regulate gene expression. A second endogenous small RNA class, the Piwi-interacting RNAs, bind Piwi proteins and suppress transposons. Piwi-interacting RNAs are restricted to the gonad, and at least a subset of these arises by Piwi-catalysed cleavage of single-stranded RNAs. Here we show that Drosophila generates a third small RNA class, endogenous small interfering RNAs, in both gonadal and somatic tissues. Production of these RNAs requires Dicer-2, but a subset depends preferentially on Loquacious rather than the canonical Dicer-2 partner, R2D2 (ref. 14). Endogenous small interfering RNAs arise both from convergent transcription units and from structured genomic loci in a tissue-specific fashion. They predominantly join Argonaute-2 and have the capacity, as a class, to target both protein-coding genes and mobile elements. These observations expand the repertoire of small RNAs in Drosophila, adding a class that blurs distinctions based on known biogenesis mechanisms and functional roles.</p>
]]></content:encoded>
<dc:title>An endogenous small interfering RNA pathway in Drosophila</dc:title>
<dc:creator>Benjamin Czech</dc:creator>
<dc:creator>Colin D. Malone</dc:creator>
<dc:creator>Rui Zhou</dc:creator>
<dc:creator>Alexander Stark</dc:creator>
<dc:creator>Catherine Schlingeheyde</dc:creator>
<dc:creator>Monica Dus</dc:creator>
<dc:creator>Norbert Perrimon</dc:creator>
<dc:creator>Manolis Kellis</dc:creator>
<dc:creator>James A. Wohlschlegel</dc:creator>
<dc:creator>Ravi Sachidanandam</dc:creator>
<dc:creator>Gregory J. Hannon</dc:creator>
<dc:creator>Julius Brennecke</dc:creator>
<dc:identifier>doi:10.1038/nature07007</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-05-07</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-05-07</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature06923">
<title>Midzone activation of aurora B in anaphase produces an intracellular phosphorylation gradient</title>
<link>http://dx.doi.org/10.1038/nature06923</link>
<description>Proper partitioning of the contents of a cell between two daughters requires integration of spatial and temporal cues. The anaphase array of microtubules that self-organize at the spindle midzone contributes to positioning the cell-division plane midway between the segregating chromosomes. How this signalling occurs over length scales of micrometres, from the midzone to the cell cortex, is not known. Here we examine the anaphase dynamics of protein phosphorylation by aurora B kinase, a key mitotic regulator, using fluorescence resonance energy transfer (FRET)-based sensors in living  HeLa cells and immunofluorescence of native aurora B substrates. Quantitative analysis of phosphorylation dynamics, using chromosome- and centromere-targeted sensors, reveals that changes are due primarily to position along the division axis rather than time. These dynamics result in the formation of a spatial phosphorylation gradient early in anaphase that is centred at the spindle midzone. This gradient depends on aurora B targeting to a subpopulation of microtubules that activate it. Aurora kinase activity organizes the targeted microtubules to generate a structure-based feedback loop. We propose that feedback between aurora B kinase activation and midzone microtubules generates a gradient of post-translational marks that provides spatial information for events in anaphase and cytokinesis.</description>
<content:encoded><![CDATA[

<p>
<b>Midzone activation of aurora B in anaphase produces an intracellular phosphorylation gradient</b>
</p>
<p>Nature advance online publication 07 May 2008. <a href="http://dx.doi.org/10.1038/nature06923">doi:10.1038/nature06923</a>
</p>
<p>Authors: Brian G. Fuller, Michael A. Lampson, Emily A. Foley, Sara Rosasco-Nitcher, Kim V. Le, Page Tobelmann, David L. Brautigan, P. Todd Stukenberg
&amp; Tarun M. Kapoor</p>
<p>Proper partitioning of the contents of a cell between two daughters requires integration of spatial and temporal cues. The anaphase array of microtubules that self-organize at the spindle midzone contributes to positioning the cell-division plane midway between the segregating chromosomes. How this signalling occurs over length scales of micrometres, from the midzone to the cell cortex, is not known. Here we examine the anaphase dynamics of protein phosphorylation by aurora B kinase, a key mitotic regulator, using fluorescence resonance energy transfer (FRET)-based sensors in living  HeLa cells and immunofluorescence of native aurora B substrates. Quantitative analysis of phosphorylation dynamics, using chromosome- and centromere-targeted sensors, reveals that changes are due primarily to position along the division axis rather than time. These dynamics result in the formation of a spatial phosphorylation gradient early in anaphase that is centred at the spindle midzone. This gradient depends on aurora B targeting to a subpopulation of microtubules that activate it. Aurora kinase activity organizes the targeted microtubules to generate a structure-based feedback loop. We propose that feedback between aurora B kinase activation and midzone microtubules generates a gradient of post-translational marks that provides spatial information for events in anaphase and cytokinesis.</p>
]]></content:encoded>
<dc:title>Midzone activation of aurora B in anaphase produces an intracellular phosphorylation gradient</dc:title>
<dc:creator>Brian G. Fuller</dc:creator>
<dc:creator>Michael A. Lampson</dc:creator>
<dc:creator>Emily A. Foley</dc:creator>
<dc:creator>Sara Rosasco-Nitcher</dc:creator>
<dc:creator>Kim V. Le</dc:creator>
<dc:creator>Page Tobelmann</dc:creator>
<dc:creator>David L. Brautigan</dc:creator>
<dc:creator>P. Todd Stukenberg</dc:creator>
<dc:creator>Tarun M. Kapoor</dc:creator>
<dc:identifier>doi:10.1038/nature06923</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-05-07</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-05-07</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature06947">
<title>Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions</title>
<link>http://dx.doi.org/10.1038/nature06947</link>
<description>The architecture of human chromosomes in interphase nuclei is still largely unknown. Microscopy studies have indicated that specific regions of chromosomes are located in close proximity to the nuclear lamina (NL). This has led to the idea that certain genomic elements may be attached to the NL, which may contribute to the spatial organization of chromosomes inside the nucleus. However, sequences in the human genome that interact with the NL in vivo have not been identified. Here we construct a high-resolution map of the interaction sites of the entire genome with NL components in human fibroblasts. This map shows that genome&#8211;lamina interactions occur through more than 1,300 sharply defined large domains 0.1&#8211;10 megabases in size. These lamina-associated domains (LADs) are typified by low gene-expression levels, indicating that LADs represent a repressive chromatin environment. The borders of LADs are demarcated by the insulator protein CTCF, by promoters that are oriented away from LADs, or by CpG islands, suggesting possible mechanisms of LAD confinement. Taken together, these results demonstrate that the human genome is divided into large, discrete domains that are units of chromosome organization within the nucleus.</description>
<content:encoded><![CDATA[

<p>
<b>Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions</b>
</p>
<p>Nature advance online publication 07 May 2008. <a href="http://dx.doi.org/10.1038/nature06947">doi:10.1038/nature06947</a>
</p>
<p>Authors: Lars Guelen, Ludo Pagie, Emilie Brasset, Wouter Meuleman, Marius B. Faza, Wendy Talhout, Bert H. Eussen, Annelies de Klein, Lodewyk Wessels, Wouter de Laat
&amp; Bas van Steensel</p>
<p>The architecture of human chromosomes in interphase nuclei is still largely unknown. Microscopy studies have indicated that specific regions of chromosomes are located in close proximity to the nuclear lamina (NL). This has led to the idea that certain genomic elements may be attached to the NL, which may contribute to the spatial organization of chromosomes inside the nucleus. However, sequences in the human genome that interact with the NL in vivo have not been identified. Here we construct a high-resolution map of the interaction sites of the entire genome with NL components in human fibroblasts. This map shows that genome&#8211;lamina interactions occur through more than 1,300 sharply defined large domains 0.1&#8211;10 megabases in size. These lamina-associated domains (LADs) are typified by low gene-expression levels, indicating that LADs represent a repressive chromatin environment. The borders of LADs are demarcated by the insulator protein CTCF, by promoters that are oriented away from LADs, or by CpG islands, suggesting possible mechanisms of LAD confinement. Taken together, these results demonstrate that the human genome is divided into large, discrete domains that are units of chromosome organization within the nucleus.</p>
]]></content:encoded>
<dc:title>Domain organization of human chromosomes revealed by mapping of nuclear lamina interactions</dc:title>
<dc:creator>Lars Guelen</dc:creator>
<dc:creator>Ludo Pagie</dc:creator>
<dc:creator>Emilie Brasset</dc:creator>
<dc:creator>Wouter Meuleman</dc:creator>
<dc:creator>Marius B. Faza</dc:creator>
<dc:creator>Wendy Talhout</dc:creator>
<dc:creator>Bert H. Eussen</dc:creator>
<dc:creator>Annelies de Klein</dc:creator>
<dc:creator>Lodewyk Wessels</dc:creator>
<dc:creator>Wouter de Laat</dc:creator>
<dc:creator>Bas van Steensel</dc:creator>
<dc:identifier>doi:10.1038/nature06947</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-05-07</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-05-07</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature06933">
<title>Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation</title>
<link>http://dx.doi.org/10.1038/nature06933</link>
<description>Cancer stem cells, which share many common properties and regulatory machineries with normal stem cells, have recently been proposed to be responsible for tumorigenesis and to contribute to cancer resistance. The main challenges in cancer biology are to identify cancer stem cells and to define the molecular events required for transforming normal cells to cancer stem cells. Here we show that Pten deletion in mouse haematopoietic stem cells leads to a myeloproliferative disorder, followed by acute T-lymphoblastic leukaemia (T-ALL). Self-renewable leukaemia stem cells (LSCs) are enriched in the c-KitmidCD3+Lin- compartment, where unphosphorylated &#946;-catenin is significantly increased. Conditional ablation of one allele of the &#946;-catenin gene substantially decreases the incidence and delays the occurrence of T-ALL caused by Pten loss, indicating that activation of the &#946;-catenin pathway may contribute to the formation or expansion of the LSC population. Moreover, a recurring chromosomal translocation, T(14;15), results in aberrant overexpression of the c-myc oncogene in c-KitmidCD3+Lin- LSCs and CD3+ leukaemic blasts, recapitulating a subset of human T-ALL. No alterations in Notch1 signalling are detected in this model, suggesting that Pten inactivation and c-myc overexpression may substitute functionally for Notch1 abnormalities, leading to T-ALL development. Our study indicates that multiple genetic or molecular alterations contribute cooperatively to LSC transformation.</description>
<content:encoded><![CDATA[

<p>
<b>Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation</b>
</p>
<p>Nature advance online publication 07 May 2008. <a href="http://dx.doi.org/10.1038/nature06933">doi:10.1038/nature06933</a>
</p>
<p>Authors: Wei Guo, Joseph L. Lasky, Chun-Ju Chang, Sherly Mosessian, Xiaoman Lewis, Yun Xiao, Jennifer E. Yeh, James Y. Chen, M. Luisa Iruela-Arispe, Marileila Varella-Garcia
&amp; Hong Wu</p>
<p>Cancer stem cells, which share many common properties and regulatory machineries with normal stem cells, have recently been proposed to be responsible for tumorigenesis and to contribute to cancer resistance. The main challenges in cancer biology are to identify cancer stem cells and to define the molecular events required for transforming normal cells to cancer stem cells. Here we show that Pten deletion in mouse haematopoietic stem cells leads to a myeloproliferative disorder, followed by acute T-lymphoblastic leukaemia (T-ALL). Self-renewable leukaemia stem cells (LSCs) are enriched in the c-KitmidCD3+Lin- compartment, where unphosphorylated &#946;-catenin is significantly increased. Conditional ablation of one allele of the &#946;-catenin gene substantially decreases the incidence and delays the occurrence of T-ALL caused by Pten loss, indicating that activation of the &#946;-catenin pathway may contribute to the formation or expansion of the LSC population. Moreover, a recurring chromosomal translocation, T(14;15), results in aberrant overexpression of the c-myc oncogene in c-KitmidCD3+Lin- LSCs and CD3+ leukaemic blasts, recapitulating a subset of human T-ALL. No alterations in Notch1 signalling are detected in this model, suggesting that Pten inactivation and c-myc overexpression may substitute functionally for Notch1 abnormalities, leading to T-ALL development. Our study indicates that multiple genetic or molecular alterations contribute cooperatively to LSC transformation.</p>
]]></content:encoded>
<dc:title>Multi-genetic events collaboratively contribute to Pten-null leukaemia stem-cell formation</dc:title>
<dc:creator>Wei Guo</dc:creator>
<dc:creator>Joseph L. Lasky</dc:creator>
<dc:creator>Chun-Ju Chang</dc:creator>
<dc:creator>Sherly Mosessian</dc:creator>
<dc:creator>Xiaoman Lewis</dc:creator>
<dc:creator>Yun Xiao</dc:creator>
<dc:creator>Jennifer E. Yeh</dc:creator>
<dc:creator>James Y. Chen</dc:creator>
<dc:creator>M. Luisa Iruela-Arispe</dc:creator>
<dc:creator>Marileila Varella-Garcia</dc:creator>
<dc:creator>Hong Wu</dc:creator>
<dc:identifier>doi:10.1038/nature06933</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-05-07</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-05-07</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature06938">
<title>Drosophila endogenous small RNAs bind to Argonaute&#8201;2 in somatic cells</title>
<link>http://dx.doi.org/10.1038/nature06938</link>
<description>RNA silencing is a conserved mechanism in which small RNAs trigger various forms of sequence-specific gene silencing by guiding Argonaute complexes to target RNAs by means of base pairing. RNA silencing is thought to have evolved as a form of nucleic-acid-based immunity to inactivate viruses and transposable elements. Although the activity of transposable elements in animals has been thought largely to be restricted to the germ line, recent studies have shown that they may also actively transpose in somatic cells, creating somatic mosaicism in animals. In the Drosophila germ line, Piwi-interacting RNAs arise from repetitive intergenic elements including retrotransposons by a Dicer-independent pathway and function through the Piwi subfamily of Argonautes to ensure silencing of retrotransposons. Here we show that, in cultured Drosophila S2 cells, Argonaute&#8201;2 (AGO2), an AGO subfamily member of Argonautes, associates with endogenous small RNAs of 20&#8211;22 nucleotides in length, which we have collectively named endogenous short interfering RNAs (esiRNAs). esiRNAs can be divided into two groups: one that mainly corresponds to a subset of retrotransposons, and the other that arises from stem&#8211;loop structures. esiRNAs are produced in a Dicer-2-dependent manner from distinctive genomic loci, are modified at their 3&#8242; ends and can direct AGO2 to cleave target RNAs. Mutations in Dicer-2 caused an increase in retrotransposon transcripts. Together, our findings indicate that different types of small RNAs and Argonautes are used to repress retrotransposons in germline and somatic cells in Drosophila.</description>
<content:encoded><![CDATA[

<p>
<b>Drosophila endogenous small RNAs bind to Argonaute&#8201;2 in somatic cells</b>
</p>
<p>Nature advance online publication 07 May 2008. <a href="http://dx.doi.org/10.1038/nature06938">doi:10.1038/nature06938</a>
</p>
<p>Authors: Yoshinori Kawamura, Kuniaki Saito, Taishin Kin, Yukiteru Ono, Kiyoshi Asai, Takafumi Sunohara, Tomoko N. Okada, Mikiko C. Siomi
&amp; Haruhiko Siomi</p>
<p>RNA silencing is a conserved mechanism in which small RNAs trigger various forms of sequence-specific gene silencing by guiding Argonaute complexes to target RNAs by means of base pairing. RNA silencing is thought to have evolved as a form of nucleic-acid-based immunity to inactivate viruses and transposable elements. Although the activity of transposable elements in animals has been thought largely to be restricted to the germ line, recent studies have shown that they may also actively transpose in somatic cells, creating somatic mosaicism in animals. In the Drosophila germ line, Piwi-interacting RNAs arise from repetitive intergenic elements including retrotransposons by a Dicer-independent pathway and function through the Piwi subfamily of Argonautes to ensure silencing of retrotransposons. Here we show that, in cultured Drosophila S2 cells, Argonaute&#8201;2 (AGO2), an AGO subfamily member of Argonautes, associates with endogenous small RNAs of 20&#8211;22 nucleotides in length, which we have collectively named endogenous short interfering RNAs (esiRNAs). esiRNAs can be divided into two groups: one that mainly corresponds to a subset of retrotransposons, and the other that arises from stem&#8211;loop structures. esiRNAs are produced in a Dicer-2-dependent manner from distinctive genomic loci, are modified at their 3&#8242; ends and can direct AGO2 to cleave target RNAs. Mutations in Dicer-2 caused an increase in retrotransposon transcripts. Together, our findings indicate that different types of small RNAs and Argonautes are used to repress retrotransposons in germline and somatic cells in Drosophila.</p>
]]></content:encoded>
<dc:title>Drosophila endogenous small RNAs bind to Argonaute&#8201;2 in somatic cells</dc:title>
<dc:creator>Yoshinori Kawamura</dc:creator>
<dc:creator>Kuniaki Saito</dc:creator>
<dc:creator>Taishin Kin</dc:creator>
<dc:creator>Yukiteru Ono</dc:creator>
<dc:creator>Kiyoshi Asai</dc:creator>
<dc:creator>Takafumi Sunohara</dc:creator>
<dc:creator>Tomoko N. Okada</dc:creator>
<dc:creator>Mikiko C. Siomi</dc:creator>
<dc:creator>Haruhiko Siomi</dc:creator>
<dc:identifier>doi:10.1038/nature06938</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-05-07</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-05-07</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature06943">
<title>Cytokinin and auxin interaction in root stem-cell specification during early embryogenesis</title>
<link>http://dx.doi.org/10.1038/nature06943</link>
<description>Plant stem-cell pools, the source for all organs, are first established during embryogenesis. It has been known for decades that cytokinin and auxin interact to control organ regeneration in cultured tissue. Auxin has a critical role in root stem-cell specification in zygotic embryogenesis, but the early embryonic function of cytokinin is obscure. Here, we introduce a synthetic reporter to visualize universally cytokinin output in vivo. Notably, the first embryonic signal is detected in the hypophysis, the founder cell of the root stem-cell system. Its apical daughter cell, the precursor of the quiescent centre, maintains phosphorelay activity, whereas the basal daughter cell represses signalling output. Auxin activity levels, however, exhibit the inverse profile. Furthermore, we show that auxin antagonizes cytokinin output in the basal cell lineage by direct transcriptional activation of ARABIDOPSIS RESPONSE REGULATOR genes, ARR7 and ARR15, feedback repressors of cytokinin signalling. Loss of ARR7 and ARR15 function or ectopic cytokinin signalling in the basal cell during early embryogenesis results in a defective root stem-cell system. These results provide a molecular model of transient and antagonistic interaction between auxin and cytokinin critical for specifying the first root stem-cell niche.</description>
<content:encoded><![CDATA[

<p>
<b>Cytokinin and auxin interaction in root stem-cell specification during early embryogenesis</b>
</p>
<p>Nature advance online publication 07 May 2008. <a href="http://dx.doi.org/10.1038/nature06943">doi:10.1038/nature06943</a>
</p>
<p>Authors: Bruno M&#252;ller
&amp; Jen Sheen</p>
<p>Plant stem-cell pools, the source for all organs, are first established during embryogenesis. It has been known for decades that cytokinin and auxin interact to control organ regeneration in cultured tissue. Auxin has a critical role in root stem-cell specification in zygotic embryogenesis, but the early embryonic function of cytokinin is obscure. Here, we introduce a synthetic reporter to visualize universally cytokinin output in vivo. Notably, the first embryonic signal is detected in the hypophysis, the founder cell of the root stem-cell system. Its apical daughter cell, the precursor of the quiescent centre, maintains phosphorelay activity, whereas the basal daughter cell represses signalling output. Auxin activity levels, however, exhibit the inverse profile. Furthermore, we show that auxin antagonizes cytokinin output in the basal cell lineage by direct transcriptional activation of ARABIDOPSIS RESPONSE REGULATOR genes, ARR7 and ARR15, feedback repressors of cytokinin signalling. Loss of ARR7 and ARR15 function or ectopic cytokinin signalling in the basal cell during early embryogenesis results in a defective root stem-cell system. These results provide a molecular model of transient and antagonistic interaction between auxin and cytokinin critical for specifying the first root stem-cell niche.</p>
]]></content:encoded>
<dc:title>Cytokinin and auxin interaction in root stem-cell specification during early embryogenesis</dc:title>
<dc:creator>Bruno M&#252;ller</dc:creator>
<dc:creator>Jen Sheen</dc:creator>
<dc:identifier>doi:10.1038/nature06943</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-05-07</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-05-07</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature07015">
<title>The Drosophila hairpin RNA pathway generates endogenous short interfering RNAs</title>
<link>http://dx.doi.org/10.1038/nature07015</link>
<description>In contrast to microRNAs and Piwi-associated RNAs, short interfering RNAs (siRNAs) are seemingly dispensable for host-directed gene regulation in Drosophila. This notion is based on the fact that mutants lacking the core siRNA-generating enzyme Dicer-2 or the predominant siRNA effector Argonaute 2 are viable, fertile and of relatively normal morphology. Moreover, endogenous Drosophila siRNAs have not yet been identified. Here we report that siRNAs derived from long hairpin RNA genes (hpRNAs) programme Slicer complexes that can repress endogenous target transcripts. The Drosophila hpRNA pathway is a hybrid mechanism that combines canonical RNA interference factors (Dicer-2, Hen1 (known as CG12367) and Argonaute 2) with a canonical microRNA factor (Loquacious) to generate &#8764;21-nucleotide siRNAs. These novel regulatory RNAs reveal unexpected complexity in the sorting of small RNAs, and open a window onto the biological usage of endogenous RNA interference in Drosophila.</description>
<content:encoded><![CDATA[

<p>
<b>The Drosophila hairpin RNA pathway generates endogenous short interfering RNAs</b>
</p>
<p>Nature advance online publication 07 May 2008. <a href="http://dx.doi.org/10.1038/nature07015">doi:10.1038/nature07015</a>
</p>
<p>Authors: Katsutomo Okamura, Wei-Jen Chung, J. Graham Ruby, Huili Guo, David P. Bartel
&amp; Eric C. Lai</p>
<p>In contrast to microRNAs and Piwi-associated RNAs, short interfering RNAs (siRNAs) are seemingly dispensable for host-directed gene regulation in Drosophila. This notion is based on the fact that mutants lacking the core siRNA-generating enzyme Dicer-2 or the predominant siRNA effector Argonaute 2 are viable, fertile and of relatively normal morphology. Moreover, endogenous Drosophila siRNAs have not yet been identified. Here we report that siRNAs derived from long hairpin RNA genes (hpRNAs) programme Slicer complexes that can repress endogenous target transcripts. The Drosophila hpRNA pathway is a hybrid mechanism that combines canonical RNA interference factors (Dicer-2, Hen1 (known as CG12367) and Argonaute 2) with a canonical microRNA factor (Loquacious) to generate &#8764;21-nucleotide siRNAs. These novel regulatory RNAs reveal unexpected complexity in the sorting of small RNAs, and open a window onto the biological usage of endogenous RNA interference in Drosophila.</p>
]]></content:encoded>
<dc:title>The Drosophila hairpin RNA pathway generates endogenous short interfering RNAs</dc:title>
<dc:creator>Katsutomo Okamura</dc:creator>
<dc:creator>Wei-Jen Chung</dc:creator>
<dc:creator>J. Graham Ruby</dc:creator>
<dc:creator>Huili Guo</dc:creator>
<dc:creator>David P. Bartel</dc:creator>
<dc:creator>Eric C. Lai</dc:creator>
<dc:identifier>doi:10.1038/nature07015</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-05-07</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-05-07</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature06955">
<title>Global control of cell-cycle transcription by coupled CDK and network oscillators</title>
<link>http://dx.doi.org/10.1038/nature06955</link>
<description>A significant fraction of the Saccharomyces cerevisiae genome is transcribed periodically during the cell division cycle, indicating that properly timed gene expression is important for regulating cell-cycle events. Genomic analyses of the localization and expression dynamics of transcription factors suggest that a network of sequentially expressed transcription factors could control the temporal programme of transcription during the cell cycle. However, directed studies interrogating small numbers of genes indicate that their periodic transcription is governed by the activity of cyclin-dependent kinases (CDKs). To determine the extent to which the global cell-cycle transcription programme is controlled by cyclin&#8211;CDK complexes, we examined genome-wide transcription dynamics in budding yeast mutant cells that do not express S-phase and mitotic cyclins. Here we show that a significant fraction of periodic genes are aberrantly expressed in the cyclin mutant. Although cells lacking cyclins are blocked at the G1/S border, nearly 70% of periodic genes continued to be expressed periodically and on schedule. Our findings reveal that although CDKs have a function in the regulation of cell-cycle transcription, they are not solely responsible for establishing the global periodic transcription programme. We propose that periodic transcription is an emergent property of a transcription factor network that can function as a cell-cycle oscillator independently of, and in tandem with, the CDK oscillator.</description>
<content:encoded><![CDATA[

<p>
<b>Global control of cell-cycle transcription by coupled CDK and network oscillators</b>
</p>
<p>Nature advance online publication 07 May 2008. <a href="http://dx.doi.org/10.1038/nature06955">doi:10.1038/nature06955</a>
</p>
<p>Authors: David A. Orlando, Charles Y. Lin, Allister Bernard, Jean Y. Wang, Joshua E. S. Socolar, Edwin S. Iversen, Alexander J. Hartemink
&amp; Steven B. Haase</p>
<p>A significant fraction of the Saccharomyces cerevisiae genome is transcribed periodically during the cell division cycle, indicating that properly timed gene expression is important for regulating cell-cycle events. Genomic analyses of the localization and expression dynamics of transcription factors suggest that a network of sequentially expressed transcription factors could control the temporal programme of transcription during the cell cycle. However, directed studies interrogating small numbers of genes indicate that their periodic transcription is governed by the activity of cyclin-dependent kinases (CDKs). To determine the extent to which the global cell-cycle transcription programme is controlled by cyclin&#8211;CDK complexes, we examined genome-wide transcription dynamics in budding yeast mutant cells that do not express S-phase and mitotic cyclins. Here we show that a significant fraction of periodic genes are aberrantly expressed in the cyclin mutant. Although cells lacking cyclins are blocked at the G1/S border, nearly 70% of periodic genes continued to be expressed periodically and on schedule. Our findings reveal that although CDKs have a function in the regulation of cell-cycle transcription, they are not solely responsible for establishing the global periodic transcription programme. We propose that periodic transcription is an emergent property of a transcription factor network that can function as a cell-cycle oscillator independently of, and in tandem with, the CDK oscillator.</p>
]]></content:encoded>
<dc:title>Global control of cell-cycle transcription by coupled CDK and network oscillators</dc:title>
<dc:creator>David A. Orlando</dc:creator>
<dc:creator>Charles Y. Lin</dc:creator>
<dc:creator>Allister Bernard</dc:creator>
<dc:creator>Jean Y. Wang</dc:creator>
<dc:creator>Joshua E. S. Socolar</dc:creator>
<dc:creator>Edwin S. Iversen</dc:creator>
<dc:creator>Alexander J. Hartemink</dc:creator>
<dc:creator>Steven B. Haase</dc:creator>
<dc:identifier>doi:10.1038/nature06955</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-05-07</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-05-07</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature06910">
<title>Neural substrates of vocalization feedback monitoring in primate auditory cortex</title>
<link>http://dx.doi.org/10.1038/nature06910</link>
<description>Vocal communication involves both speaking and hearing, often taking place concurrently. Vocal production, including human speech and animal vocalization, poses a number of unique challenges for the auditory system. It is important for the auditory system to monitor external sounds continuously from the acoustic environment during speaking despite the potential for sensory masking by self-generated sounds. It is also essential for the auditory system to monitor feedback of one&#8217;s own voice. This self-monitoring may play a part in distinguishing between self-generated or externally generatedauditory inputs and in detecting errors in our vocal production. Previous work in humans and other animals has demonstrated that the auditory cortex is largely suppressed during speaking or vocalizing. Despite the importance of self-monitoring, the underlying neural mechanisms in the mammalian brain, in particular the role of vocalization-induced suppression, remain virtually unknown. Here we show that neurons in the auditory cortex of marmoset monkeys (Callithrix jacchus) are sensitive to auditory feedback during vocal production, and that changes in the feedback alter the coding properties of these neurons. Furthermore, we found that the previously described cortical suppression during vocalization actually increased the sensitivity of these neurons to vocal feedback. This heightened sensitivity to vocal feedback suggests that these neurons may have an important role in auditory self-monitoring.</description>
<content:encoded><![CDATA[

<p>
<b>Neural substrates of vocalization feedback monitoring in primate auditory cortex</b>
</p>
<p>Nature advance online publication 04 May 2008. <a href="http://dx.doi.org/10.1038/nature06910">doi:10.1038/nature06910</a>
</p>
<p>Authors: Steven J. Eliades
&amp; Xiaoqin Wang</p>
<p>Vocal communication involves both speaking and hearing, often taking place concurrently. Vocal production, including human speech and animal vocalization, poses a number of unique challenges for the auditory system. It is important for the auditory system to monitor external sounds continuously from the acoustic environment during speaking despite the potential for sensory masking by self-generated sounds. It is also essential for the auditory system to monitor feedback of one&#8217;s own voice. This self-monitoring may play a part in distinguishing between self-generated or externally generatedauditory inputs and in detecting errors in our vocal production. Previous work in humans and other animals has demonstrated that the auditory cortex is largely suppressed during speaking or vocalizing. Despite the importance of self-monitoring, the underlying neural mechanisms in the mammalian brain, in particular the role of vocalization-induced suppression, remain virtually unknown. Here we show that neurons in the auditory cortex of marmoset monkeys (Callithrix jacchus) are sensitive to auditory feedback during vocal production, and that changes in the feedback alter the coding properties of these neurons. Furthermore, we found that the previously described cortical suppression during vocalization actually increased the sensitivity of these neurons to vocal feedback. This heightened sensitivity to vocal feedback suggests that these neurons may have an important role in auditory self-monitoring.</p>
]]></content:encoded>
<dc:title>Neural substrates of vocalization feedback monitoring in primate auditory cortex</dc:title>
<dc:creator>Steven J. Eliades</dc:creator>
<dc:creator>Xiaoqin Wang</dc:creator>
<dc:identifier>doi:10.1038/nature06910</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-05-04</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-05-04</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature06891">
<title>Cladistic analysis of continuous modularized traits provides phylogenetic signals in Homo evolution</title>
<link>http://dx.doi.org/10.1038/nature06891</link>
<description>Evolutionary novelties in the skeleton are usually expressed as changes in the timing of growth of features intrinsically integrated at different hierarchical levels of development. As a consequence, most of the shape-traits observed across species do vary quantitatively rather than qualitatively, in a multivariate space and in a modularized way. Because most phylogenetic analyses normally use discrete, hypothetically independent characters, previous attempts have disregarded the phylogenetic signals potentially enclosed in the shape of morphological structures. When analysing low taxonomic levels, where most variation is quantitative in nature, solving basic requirements like the choice of characters and the capacity of using continuous, integrated traits is of crucial importance in recovering wider phylogenetic information. This is particularly relevant when analysing extinct lineages, where available data are limited to fossilized structures. Here we show that when continuous, multivariant and modularized characters are treated as such, cladistic analysis successfully solves relationships among main Homo taxa. Our attempt is based on a combination of cladistics, evolutionary-development-derived selection of characters, and geometric morphometrics methods. In contrast with previous cladistic analyses of hominid phylogeny, our method accounts for the quantitative nature of the traits, and respects their morphological integration patterns. Because complex phenotypes are observable across different taxonomic groups and are potentially informative about phylogenetic relationships, future analyses should point strongly to the incorporation of these types of trait.</description>
<content:encoded><![CDATA[

<p>
<b>Cladistic analysis of continuous modularized traits provides phylogenetic signals in Homo evolution</b>
</p>
<p>Nature advance online publication 04 May 2008. <a href="http://dx.doi.org/10.1038/nature06891">doi:10.1038/nature06891</a>
</p>
<p>Authors: Rolando Gonz&#225;lez-Jos&#233;, Ignacio Escapa, Walter A. Neves, Rub&#233;n C&#250;neo
&amp; H&#233;ctor M. Pucciarelli</p>
<p>Evolutionary novelties in the skeleton are usually expressed as changes in the timing of growth of features intrinsically integrated at different hierarchical levels of development. As a consequence, most of the shape-traits observed across species do vary quantitatively rather than qualitatively, in a multivariate space and in a modularized way. Because most phylogenetic analyses normally use discrete, hypothetically independent characters, previous attempts have disregarded the phylogenetic signals potentially enclosed in the shape of morphological structures. When analysing low taxonomic levels, where most variation is quantitative in nature, solving basic requirements like the choice of characters and the capacity of using continuous, integrated traits is of crucial importance in recovering wider phylogenetic information. This is particularly relevant when analysing extinct lineages, where available data are limited to fossilized structures. Here we show that when continuous, multivariant and modularized characters are treated as such, cladistic analysis successfully solves relationships among main Homo taxa. Our attempt is based on a combination of cladistics, evolutionary-development-derived selection of characters, and geometric morphometrics methods. In contrast with previous cladistic analyses of hominid phylogeny, our method accounts for the quantitative nature of the traits, and respects their morphological integration patterns. Because complex phenotypes are observable across different taxonomic groups and are potentially informative about phylogenetic relationships, future analyses should point strongly to the incorporation of these types of trait.</p>
]]></content:encoded>
<dc:title>Cladistic analysis of continuous modularized traits provides phylogenetic signals in Homo evolution</dc:title>
<dc:creator>Rolando Gonz&#225;lez-Jos&#233;</dc:creator>
<dc:creator>Ignacio Escapa</dc:creator>
<dc:creator>Walter A. Neves</dc:creator>
<dc:creator>Rub&#233;n C&#250;neo</dc:creator>
<dc:creator>H&#233;ctor M. Pucciarelli</dc:creator>
<dc:identifier>doi:10.1038/nature06891</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-05-04</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-05-04</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature07006">
<title>Essential role for Nix in autophagic maturation of erythroid cells</title>
<link>http://dx.doi.org/10.1038/nature07006</link>
<description>Erythroid cells undergo enucleation and the removal of organelles during terminal differentiation. Although autophagy has been suggested to mediate the elimination of organelles for erythroid maturation, the molecular mechanisms underlying this process remain undefined. Here we report a role for a Bcl-2 family member, Nix (also called Bnip3L), in the regulation of erythroid maturation through mitochondrial autophagy. Nix-/- mice developed anaemia with reduced mature erythrocytes and compensatory expansion of erythroid precursors. Erythrocytes in the peripheral blood of Nix-/- mice exhibited mitochondrial retention and reduced lifespan in vivo. Although the clearance of ribosomes proceeded normally in the absence of Nix, the entry of mitochondria into autophagosomes for clearance was defective. Deficiency in Nix inhibited the loss of mitochondrial membrane potential (&#916;&#936;m), and treatment with uncoupling chemicals or a BH3 mimetic induced the loss of &#916;&#936;m and restored the sequestration of mitochondria into autophagosomes in Nix-/- erythroid cells. These results suggest that Nix-dependent loss of &#916;&#936;m is important for targeting the mitochondria into autophagosomes for clearance during erythroid maturation, and interference with this function impairs erythroid maturation and results in anaemia. Our study may also provide insights into molecular mechanisms underlying mitochondrial quality control involving mitochondrial autophagy.</description>
<content:encoded><![CDATA[

<p>
<b>Essential role for Nix in autophagic maturation of erythroid cells</b>
</p>
<p>Nature advance online publication 04 May 2008. <a href="http://dx.doi.org/10.1038/nature07006">doi:10.1038/nature07006</a>
</p>
<p>Authors: Hector Sandoval, Perumal Thiagarajan, Swapan K. Dasgupta, Armin Schumacher, Josef T. Prchal, Min Chen
&amp; Jin Wang</p>
<p>Erythroid cells undergo enucleation and the removal of organelles during terminal differentiation. Although autophagy has been suggested to mediate the elimination of organelles for erythroid maturation, the molecular mechanisms underlying this process remain undefined. Here we report a role for a Bcl-2 family member, Nix (also called Bnip3L), in the regulation of erythroid maturation through mitochondrial autophagy. Nix-/- mice developed anaemia with reduced mature erythrocytes and compensatory expansion of erythroid precursors. Erythrocytes in the peripheral blood of Nix-/- mice exhibited mitochondrial retention and reduced lifespan in vivo. Although the clearance of ribosomes proceeded normally in the absence of Nix, the entry of mitochondria into autophagosomes for clearance was defective. Deficiency in Nix inhibited the loss of mitochondrial membrane potential (&#916;&#936;m), and treatment with uncoupling chemicals or a BH3 mimetic induced the loss of &#916;&#936;m and restored the sequestration of mitochondria into autophagosomes in Nix-/- erythroid cells. These results suggest that Nix-dependent loss of &#916;&#936;m is important for targeting the mitochondria into autophagosomes for clearance during erythroid maturation, and interference with this function impairs erythroid maturation and results in anaemia. Our study may also provide insights into molecular mechanisms underlying mitochondrial quality control involving mitochondrial autophagy.</p>
]]></content:encoded>
<dc:title>Essential role for Nix in autophagic maturation of erythroid cells</dc:title>
<dc:creator>Hector Sandoval</dc:creator>
<dc:creator>Perumal Thiagarajan</dc:creator>
<dc:creator>Swapan K. Dasgupta</dc:creator>
<dc:creator>Armin Schumacher</dc:creator>
<dc:creator>Josef T. Prchal</dc:creator>
<dc:creator>Min Chen</dc:creator>
<dc:creator>Jin Wang</dc:creator>
<dc:identifier>doi:10.1038/nature07006</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-05-04</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-05-04</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature06944">
<title>Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer</title>
<link>http://dx.doi.org/10.1038/nature06944</link>
<description>The mammalian Y chromosome acts as a dominant male determinant as a result of the action of a single gene, Sry, whose role in sex determination is to initiate testis rather than ovary development from early bipotential gonads. It does so by triggering the differentiation of Sertoli cells from supporting cell precursors, which would otherwise give follicle cells. The related autosomal gene Sox9 is also known from loss-of-function mutations in mice and humans to be essential for Sertoli cell differentiation; moreover, its abnormal expression in an XX gonad can lead to male development in the absence of Sry. These genetic data, together with the finding that Sox9 is upregulated in Sertoli cell precursors just after SRY expression begins, has led to the proposal that Sox9 could be directly regulated by SRY. However, the mechanism by which SRY action might affect Sox9 expression was not understood. Here we show that SRY binds to multiple elements within a Sox9 gonad-specific enhancer in mice, and that it does so along with steroidogenic factor 1 (SF1, encoded by the gene Nr5a1 (Sf1)), an orphan nuclear receptor. Mutation, co-transfection and sex-reversal studies all point to a feedforward, self-reinforcing pathway in which SF1 and SRY cooperatively upregulate Sox9 and then, together with SF1, SOX9 also binds to the enhancer to help maintain its own expression after that of SRY has ceased. Our results open up the field, permitting further characterization of the molecular mechanisms regulating sex determination and how they have evolved, as well as how they fail in cases of sex reversal.</description>
<content:encoded><![CDATA[

<p>
<b>Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer</b>
</p>
<p>Nature advance online publication 04 May 2008. <a href="http://dx.doi.org/10.1038/nature06944">doi:10.1038/nature06944</a>
</p>
<p>Authors: Ryohei Sekido
&amp; Robin Lovell-Badge</p>
<p>The mammalian Y chromosome acts as a dominant male determinant as a result of the action of a single gene, Sry, whose role in sex determination is to initiate testis rather than ovary development from early bipotential gonads. It does so by triggering the differentiation of Sertoli cells from supporting cell precursors, which would otherwise give follicle cells. The related autosomal gene Sox9 is also known from loss-of-function mutations in mice and humans to be essential for Sertoli cell differentiation; moreover, its abnormal expression in an XX gonad can lead to male development in the absence of Sry. These genetic data, together with the finding that Sox9 is upregulated in Sertoli cell precursors just after SRY expression begins, has led to the proposal that Sox9 could be directly regulated by SRY. However, the mechanism by which SRY action might affect Sox9 expression was not understood. Here we show that SRY binds to multiple elements within a Sox9 gonad-specific enhancer in mice, and that it does so along with steroidogenic factor 1 (SF1, encoded by the gene Nr5a1 (Sf1)), an orphan nuclear receptor. Mutation, co-transfection and sex-reversal studies all point to a feedforward, self-reinforcing pathway in which SF1 and SRY cooperatively upregulate Sox9 and then, together with SF1, SOX9 also binds to the enhancer to help maintain its own expression after that of SRY has ceased. Our results open up the field, permitting further characterization of the molecular mechanisms regulating sex determination and how they have evolved, as well as how they fail in cases of sex reversal.</p>
]]></content:encoded>
<dc:title>Sex determination involves synergistic action of SRY and SF1 on a specific Sox9 enhancer</dc:title>
<dc:creator>Ryohei Sekido</dc:creator>
<dc:creator>Robin Lovell-Badge</dc:creator>
<dc:identifier>doi:10.1038/nature06944</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-05-04</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-05-04</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature06902">
<title>Dynamics of fat cell turnover in humans</title>
<link>http://dx.doi.org/10.1038/nature06902</link>
<description>Obesity is increasing in an epidemic manner in most countries and constitutes a public health problem by enhancing the risk for cardiovascular disease and metabolic disorders such as type 2 diabetes. Owing to the increase in obesity, life expectancy may start to decrease in developed countries for the first time in recent history. The factors determining fat mass in adult humans are not fully understood, but increased lipid storage in already developed fat cells (adipocytes) is thought to be most important. Here we show that adipocyte number is a major determinant for the fat mass in adults. However, the number of fat cells stays constant in adulthood in lean and obese individuals, even after marked weight loss, indicating that the number of adipocytes is set during childhood and adolescence. To establish the dynamics within the stable population of adipocytes in adults, we have measured adipocyte turnover by analysing the integration of 14C derived from nuclear bomb tests in genomic DNA. Approximately 10% of fat cells are renewed annually at all adult ages and levels of body mass index. Neither adipocyte death nor generation rate is altered in early onset obesity, suggesting a tight regulation of fat cell number in this condition during adulthood. The high turnover of adipocytes establishes a new therapeutic target for pharmacological intervention in obesity.</description>
<content:encoded><![CDATA[

<p>
<b>Dynamics of fat cell turnover in humans</b>
</p>
<p>Nature advance online publication 04 May 2008. <a href="http://dx.doi.org/10.1038/nature06902">doi:10.1038/nature06902</a>
</p>
<p>Authors: Kirsty L. Spalding, Erik Arner, P&#229;l O. Westermark, Samuel Bernard, Bruce A. Buchholz, Olaf Bergmann, Lennart Blomqvist, Johan Hoffstedt, Erik N&#228;slund, Tom Britton, Hernan Concha, Moustapha Hassan, Mikael Ryd&#233;n, Jonas Fris&#233;n
&amp; Peter Arner</p>
<p>Obesity is increasing in an epidemic manner in most countries and constitutes a public health problem by enhancing the risk for cardiovascular disease and metabolic disorders such as type 2 diabetes. Owing to the increase in obesity, life expectancy may start to decrease in developed countries for the first time in recent history. The factors determining fat mass in adult humans are not fully understood, but increased lipid storage in already developed fat cells (adipocytes) is thought to be most important. Here we show that adipocyte number is a major determinant for the fat mass in adults. However, the number of fat cells stays constant in adulthood in lean and obese individuals, even after marked weight loss, indicating that the number of adipocytes is set during childhood and adolescence. To establish the dynamics within the stable population of adipocytes in adults, we have measured adipocyte turnover by analysing the integration of 14C derived from nuclear bomb tests in genomic DNA. Approximately 10% of fat cells are renewed annually at all adult ages and levels of body mass index. Neither adipocyte death nor generation rate is altered in early onset obesity, suggesting a tight regulation of fat cell number in this condition during adulthood. The high turnover of adipocytes establishes a new therapeutic target for pharmacological intervention in obesity.</p>
]]></content:encoded>
<dc:title>Dynamics of fat cell turnover in humans</dc:title>
<dc:creator>Kirsty L. Spalding</dc:creator>
<dc:creator>Erik Arner</dc:creator>
<dc:creator>P&#229;l O. Westermark</dc:creator>
<dc:creator>Samuel Bernard</dc:creator>
<dc:creator>Bruce A. Buchholz</dc:creator>
<dc:creator>Olaf Bergmann</dc:creator>
<dc:creator>Lennart Blomqvist</dc:creator>
<dc:creator>Johan Hoffstedt</dc:creator>
<dc:creator>Erik N&#228;slund</dc:creator>
<dc:creator>Tom Britton</dc:creator>
<dc:creator>Hernan Concha</dc:creator>
<dc:creator>Moustapha Hassan</dc:creator>
<dc:creator>Mikael Ryd&#233;n</dc:creator>
<dc:creator>Jonas Fris&#233;n</dc:creator>
<dc:creator>Peter Arner</dc:creator>
<dc:identifier>doi:10.1038/nature06902</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-05-04</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-05-04</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature06892">
<title>Angiogenesis selectively requires the p110&#945; isoform of PI3K to control endothelial cell migration</title>
<link>http://dx.doi.org/10.1038/nature06892</link>
<description>Phosphoinositide 3-kinases (PI3Ks) signal downstream of multiple cell-surface receptor types. Class IA PI3K isoforms couple to tyrosine kinases and consist of a p110 catalytic subunit (p110&#945;, p110&#946; or p110&#948;), constitutively bound to one of five distinct p85 regulatory subunits. PI3Ks have been implicated in angiogenesis, but little is known about potential selectivity among the PI3K isoforms and their mechanism of action in endothelial cells during angiogenesis in vivo. Here we show that only p110&#945; activity is essential for vascular development. Ubiquitous or endothelial cell-specific inactivation of p110&#945; led to embryonic lethality at mid-gestation because of severe defects in angiogenic sprouting and vascular remodelling. p110&#945; exerts this critical endothelial cell-autonomous function by regulating endothelial cell migration through the small GTPase RhoA. p110&#945; activity is particularly high in endothelial cells and preferentially induced by tyrosine kinase ligands (such as vascular endothelial growth factor (VEGF)-A). In contrast, p110&#946; in endothelial cells signals downstream of G-protein-coupled receptor (GPCR) ligands such as SDF-1&#945;, whereas p110&#948; is expressed at low level and contributes only minimally to PI3K activity in endothelial cells. These results provide the first in vivo evidence for p110-isoform selectivity in endothelial PI3K signalling during angiogenesis.</description>
<content:encoded><![CDATA[

<p>
<b>Angiogenesis selectively requires the p110&#945; isoform of PI3K to control endothelial cell migration</b>
</p>
<p>Nature advance online publication 30 April 2008. <a href="http://dx.doi.org/10.1038/nature06892">doi:10.1038/nature06892</a>
</p>
<p>Authors: Mariona Graupera, Julie Guillermet-Guibert, Lazaros C. Foukas, Li-Kun Phng, Robert J. Cain, Ashreena Salpekar, Wayne Pearce, Stephen Meek, Jaime Millan, Pedro R. Cutillas, Andrew J. H. Smith, Anne J. Ridley, Christiana Ruhrberg, Holger Gerhardt
&amp; Bart Vanhaesebroeck</p>
<p>Phosphoinositide 3-kinases (PI3Ks) signal downstream of multiple cell-surface receptor types. Class IA PI3K isoforms couple to tyrosine kinases and consist of a p110 catalytic subunit (p110&#945;, p110&#946; or p110&#948;), constitutively bound to one of five distinct p85 regulatory subunits. PI3Ks have been implicated in angiogenesis, but little is known about potential selectivity among the PI3K isoforms and their mechanism of action in endothelial cells during angiogenesis in vivo. Here we show that only p110&#945; activity is essential for vascular development. Ubiquitous or endothelial cell-specific inactivation of p110&#945; led to embryonic lethality at mid-gestation because of severe defects in angiogenic sprouting and vascular remodelling. p110&#945; exerts this critical endothelial cell-autonomous function by regulating endothelial cell migration through the small GTPase RhoA. p110&#945; activity is particularly high in endothelial cells and preferentially induced by tyrosine kinase ligands (such as vascular endothelial growth factor (VEGF)-A). In contrast, p110&#946; in endothelial cells signals downstream of G-protein-coupled receptor (GPCR) ligands such as SDF-1&#945;, whereas p110&#948; is expressed at low level and contributes only minimally to PI3K activity in endothelial cells. These results provide the first in vivo evidence for p110-isoform selectivity in endothelial PI3K signalling during angiogenesis.</p>
]]></content:encoded>
<dc:title>Angiogenesis selectively requires the p110&#945; isoform of PI3K to control endothelial cell migration</dc:title>
<dc:creator>Mariona Graupera</dc:creator>
<dc:creator>Julie Guillermet-Guibert</dc:creator>
<dc:creator>Lazaros C. Foukas</dc:creator>
<dc:creator>Li-Kun Phng</dc:creator>
<dc:creator>Robert J. Cain</dc:creator>
<dc:creator>Ashreena Salpekar</dc:creator>
<dc:creator>Wayne Pearce</dc:creator>
<dc:creator>Stephen Meek</dc:creator>
<dc:creator>Jaime Millan</dc:creator>
<dc:creator>Pedro R. Cutillas</dc:creator>
<dc:creator>Andrew J. H. Smith</dc:creator>
<dc:creator>Anne J. Ridley</dc:creator>
<dc:creator>Christiana Ruhrberg</dc:creator>
<dc:creator>Holger Gerhardt</dc:creator>
<dc:creator>Bart Vanhaesebroeck</dc:creator>
<dc:identifier>doi:10.1038/nature06892</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-04-30</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-04-30</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature06907">
<title>The Cl-/H+ antiporter ClC-7 is the primary chloride permeation pathway in lysosomes</title>
<link>http://dx.doi.org/10.1038/nature06907</link>
<description>Lysosomes are the stomachs of the cell&#8212;terminal organelles on the endocytic pathway where internalized macromolecules are degraded. Containing a wide range of hydrolytic enzymes, lysosomes depend on maintaining acidic luminal pH values for efficient function. Although acidification is mediated by a V-type proton ATPase, a parallel anion pathway is essential to allow bulk proton transport. The molecular identity of this anion transporter remains unknown. Recent results of knockout experiments raise the possibility that ClC-7, a member of the CLC family of anion channels and transporters, is a contributor to this pathway in an osteoclast lysosome-like compartment, with loss of ClC-7 function causing osteopetrosis. Several mammalian members of the CLC family have been characterized in detail; some (including ClC-0, ClC-1 and ClC-2) function as Cl--conducting ion channels, whereas others act as Cl-/H+antiporters (ClC-4 and ClC-5). However, previous attempts at heterologous expression of ClC-7 have failed to yield evidence of functional protein, so it is unclear whether ClC-7 has an important function in lysosomal biology, and also whether this protein functions as a Cl- channel, a Cl-/H+ antiporter, or as something else entirely. Here we directly demonstrate an anion transport pathway in lysosomes that has the defining characteristics of a CLC Cl-/H+ antiporter and show that this transporter is the predominant route for Cl- through the lysosomal membrane. Furthermore, knockdown of ClC-7 expression by short interfering RNA can essentially ablate this lysosomal Cl-/H+ antiport activity and can strongly diminish the ability of lysosomes to acidify in vivo, demonstrating that ClC-7 is a Cl-/H+ antiporter, that it constitutes the major Cl- permeability of lysosomes, and that it is important in lysosomal acidification.</description>
<content:encoded><![CDATA[

<p>
<b>The Cl-/H+ antiporter ClC-7 is the primary chloride permeation pathway in lysosomes</b>
</p>
<p>Nature advance online publication 30 April 2008. <a href="http://dx.doi.org/10.1038/nature06907">doi:10.1038/nature06907</a>
</p>
<p>Authors: Austin R. Graves, Patricia K. Curran, Carolyn L. Smith
&amp; Joseph A. Mindell</p>
<p>Lysosomes are the stomachs of the cell&#8212;terminal organelles on the endocytic pathway where internalized macromolecules are degraded. Containing a wide range of hydrolytic enzymes, lysosomes depend on maintaining acidic luminal pH values for efficient function. Although acidification is mediated by a V-type proton ATPase, a parallel anion pathway is essential to allow bulk proton transport. The molecular identity of this anion transporter remains unknown. Recent results of knockout experiments raise the possibility that ClC-7, a member of the CLC family of anion channels and transporters, is a contributor to this pathway in an osteoclast lysosome-like compartment, with loss of ClC-7 function causing osteopetrosis. Several mammalian members of the CLC family have been characterized in detail; some (including ClC-0, ClC-1 and ClC-2) function as Cl--conducting ion channels, whereas others act as Cl-/H+antiporters (ClC-4 and ClC-5). However, previous attempts at heterologous expression of ClC-7 have failed to yield evidence of functional protein, so it is unclear whether ClC-7 has an important function in lysosomal biology, and also whether this protein functions as a Cl- channel, a Cl-/H+ antiporter, or as something else entirely. Here we directly demonstrate an anion transport pathway in lysosomes that has the defining characteristics of a CLC Cl-/H+ antiporter and show that this transporter is the predominant route for Cl- through the lysosomal membrane. Furthermore, knockdown of ClC-7 expression by short interfering RNA can essentially ablate this lysosomal Cl-/H+ antiport activity and can strongly diminish the ability of lysosomes to acidify in vivo, demonstrating that ClC-7 is a Cl-/H+ antiporter, that it constitutes the major Cl- permeability of lysosomes, and that it is important in lysosomal acidification.</p>
]]></content:encoded>
<dc:title>The Cl-/H+ antiporter ClC-7 is the primary chloride permeation pathway in lysosomes</dc:title>
<dc:creator>Austin R. Graves</dc:creator>
<dc:creator>Patricia K. Curran</dc:creator>
<dc:creator>Carolyn L. Smith</dc:creator>
<dc:creator>Joseph A. Mindell</dc:creator>
<dc:identifier>doi:10.1038/nature06907</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-04-30</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-04-30</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature06909">
<title>RNA toxicity is a component of ataxin-3 degeneration in Drosophila</title>
<link>http://dx.doi.org/10.1038/nature06909</link>
<description>Polyglutamine (polyQ) diseases are a class of dominantly inherited neurodegenerative disorders caused by the expansion of a CAG repeat encoding glutamine within the coding region of the respective genes. The molecular and cellular pathways underlying polyQ-induced neurodegeneration are the focus of much research, and it is widely considered that toxic activities of the protein, resulting from the abnormally long polyQ tract, cause pathogenesis. Here we provide evidence for a pathogenic role of the CAG repeat RNA in polyQ toxicity using Drosophila. In a Drosophila screen for modifiers of polyQ degeneration induced by the spinocerebellar ataxia type 3 (SCA3) protein ataxin-3, we isolated an upregulation allele of muscleblind (mbl), a gene implicated in the RNA toxicity of CUG expansion diseases. Further analysis indicated that there may be a toxic role of the RNA in polyQ-induced degeneration. We tested the role of the RNA by altering the CAG repeat sequence to an interrupted CAACAG repeat within the polyQ-encoding region; this dramatically mitigated toxicity. In addition, expression of an untranslated CAG repeat of pathogenic length conferred neuronal degeneration. These studies reveal a role for the RNA in polyQ toxicity, highlighting common components in RNA-based and polyQ-protein-based trinucleotide repeat expansion diseases.</description>
<content:encoded><![CDATA[

<p>
<b>RNA toxicity is a component of ataxin-3 degeneration in Drosophila</b>
</p>
<p>Nature advance online publication 30 April 2008. <a href="http://dx.doi.org/10.1038/nature06909">doi:10.1038/nature06909</a>
</p>
<p>Authors: Ling-Bo Li, Zhenming Yu, Xiuyin Teng
&amp; Nancy M. Bonini</p>
<p>Polyglutamine (polyQ) diseases are a class of dominantly inherited neurodegenerative disorders caused by the expansion of a CAG repeat encoding glutamine within the coding region of the respective genes. The molecular and cellular pathways underlying polyQ-induced neurodegeneration are the focus of much research, and it is widely considered that toxic activities of the protein, resulting from the abnormally long polyQ tract, cause pathogenesis. Here we provide evidence for a pathogenic role of the CAG repeat RNA in polyQ toxicity using Drosophila. In a Drosophila screen for modifiers of polyQ degeneration induced by the spinocerebellar ataxia type 3 (SCA3) protein ataxin-3, we isolated an upregulation allele of muscleblind (mbl), a gene implicated in the RNA toxicity of CUG expansion diseases. Further analysis indicated that there may be a toxic role of the RNA in polyQ-induced degeneration. We tested the role of the RNA by altering the CAG repeat sequence to an interrupted CAACAG repeat within the polyQ-encoding region; this dramatically mitigated toxicity. In addition, expression of an untranslated CAG repeat of pathogenic length conferred neuronal degeneration. These studies reveal a role for the RNA in polyQ toxicity, highlighting common components in RNA-based and polyQ-protein-based trinucleotide repeat expansion diseases.</p>
]]></content:encoded>
<dc:title>RNA toxicity is a component of ataxin-3 degeneration in Drosophila</dc:title>
<dc:creator>Ling-Bo Li</dc:creator>
<dc:creator>Zhenming Yu</dc:creator>
<dc:creator>Xiuyin Teng</dc:creator>
<dc:creator>Nancy M. Bonini</dc:creator>
<dc:identifier>doi:10.1038/nature06909</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-04-30</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-04-30</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature06906">
<title>Chemically ubiquitylated histone H2B stimulates hDot1L-mediated intranucleosomal methylation</title>
<link>http://dx.doi.org/10.1038/nature06906</link>
<description>Numerous post-translational modifications of histones have been described in organisms ranging from yeast to humans. Growing evidence for dynamic regulation of these modifications, position- and modification-specific protein interactions, and biochemical crosstalk between modifications has strengthened the &#8216;histone code&#8217; hypothesis, in which histone modifications are integral to choreographing the expression of the genome. One such modification, ubiquitylation of histone H2B (uH2B) on lysine 120 (K120) in humans, and lysine 123 in yeast, has been correlated with enhanced methylation of lysine 79 (K79) of histone H3 (refs 5&#8211;8), by K79-specific methyltransferase Dot1 (KMT4). However, the specific function of uH2B in this crosstalk pathway is not understood. Here we demonstrate, using chemically ubiquitylated H2B, a direct stimulation of hDot1L-mediated intranucleosomal methylation of H3 K79. Two traceless orthogonal expressed protein ligation (EPL) reactions were used to ubiquitylate H2B site-specifically. This strategy, using a photolytic ligation auxiliary and a desulphurization reaction, should be generally applicable to the chemical ubiquitylation of other proteins. Reconstitution of our uH2B into chemically defined nucleosomes, followed by biochemical analysis, revealed that uH2B directly activates methylation of H3 K79 by hDot1L. This effect is mediated through the catalytic domain of hDot1L, most likely through allosteric mechanisms. Furthermore, asymmetric incorporation of uH2B into dinucleosomes showed that the enhancement of methylation was limited to nucleosomes bearing uH2B. This work demonstrates a direct biochemical crosstalk between two modifications on separate histone proteins within a nucleosome.</description>
<content:encoded><![CDATA[

<p>
<b>Chemically ubiquitylated histone H2B stimulates hDot1L-mediated intranucleosomal methylation</b>
</p>
<p>Nature advance online publication 30 April 2008. <a href="http://dx.doi.org/10.1038/nature06906">doi:10.1038/nature06906</a>
</p>
<p>Authors: Robert K. McGinty, Jaehoon Kim, Champak Chatterjee, Robert G. Roeder
&amp; Tom W. Muir</p>
<p>Numerous post-translational modifications of histones have been described in organisms ranging from yeast to humans. Growing evidence for dynamic regulation of these modifications, position- and modification-specific protein interactions, and biochemical crosstalk between modifications has strengthened the &#8216;histone code&#8217; hypothesis, in which histone modifications are integral to choreographing the expression of the genome. One such modification, ubiquitylation of histone H2B (uH2B) on lysine 120 (K120) in humans, and lysine 123 in yeast, has been correlated with enhanced methylation of lysine 79 (K79) of histone H3 (refs 5&#8211;8), by K79-specific methyltransferase Dot1 (KMT4). However, the specific function of uH2B in this crosstalk pathway is not understood. Here we demonstrate, using chemically ubiquitylated H2B, a direct stimulation of hDot1L-mediated intranucleosomal methylation of H3 K79. Two traceless orthogonal expressed protein ligation (EPL) reactions were used to ubiquitylate H2B site-specifically. This strategy, using a photolytic ligation auxiliary and a desulphurization reaction, should be generally applicable to the chemical ubiquitylation of other proteins. Reconstitution of our uH2B into chemically defined nucleosomes, followed by biochemical analysis, revealed that uH2B directly activates methylation of H3 K79 by hDot1L. This effect is mediated through the catalytic domain of hDot1L, most likely through allosteric mechanisms. Furthermore, asymmetric incorporation of uH2B into dinucleosomes showed that the enhancement of methylation was limited to nucleosomes bearing uH2B. This work demonstrates a direct biochemical crosstalk between two modifications on separate histone proteins within a nucleosome.</p>
]]></content:encoded>
<dc:title>Chemically ubiquitylated histone H2B stimulates hDot1L-mediated intranucleosomal methylation</dc:title>
<dc:creator>Robert K. McGinty</dc:creator>
<dc:creator>Jaehoon Kim</dc:creator>
<dc:creator>Champak Chatterjee</dc:creator>
<dc:creator>Robert G. Roeder</dc:creator>
<dc:creator>Tom W. Muir</dc:creator>
<dc:identifier>doi:10.1038/nature06906</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-04-30</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-04-30</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature06883">
<title>Single-stranded DNA-binding protein hSSB1 is critical for genomic stability</title>
<link>http://dx.doi.org/10.1038/nature06883</link>
<description>Single-strand DNA (ssDNA)-binding proteins (SSBs) are ubiquitous and essential for a wide variety of DNA metabolic processes, including DNA replication, recombination, DNA damage detection and repair. SSBs have multiple roles in binding and sequestering ssDNA, detecting DNA damage, stimulating nucleases, helicases and strand-exchange proteins, activating transcription and mediating protein&#8211;protein interactions. In eukaryotes, the major SSB, replication protein A (RPA), is a heterotrimer. Here we describe a second human SSB (hSSB1), with a domain organization closer to the archaeal SSB than to RPA. Ataxia telangiectasia mutated (ATM) kinase phosphorylates hSSB1 in response to DNA double-strand breaks (DSBs). This phosphorylation event is required for DNA damage-induced stabilization of hSSB1. Upon induction of DNA damage, hSSB1 accumulates in the nucleus and forms distinct foci independent of cell-cycle phase. These foci co-localize with other known repair proteins. In contrast to RPA, hSSB1 does not localize to replication foci in S-phase cells and hSSB1 deficiency does not influence S-phase progression. Depletion of hSSB1 abrogates the cellular response to DSBs, including activation of ATM and phosphorylation of ATM targets after ionizing radiation. Cells deficient in hSSB1 exhibit increased radiosensitivity, defective checkpoint activation and enhanced genomic instability coupled with a diminished capacity for DNA repair. These findings establish that hSSB1 influences diverse endpoints in the cellular DNA damage response.</description>
<content:encoded><![CDATA[

<p>
<b>Single-stranded DNA-binding protein hSSB1 is critical for genomic stability</b>
</p>
<p>Nature advance online publication 30 April 2008. <a href="http://dx.doi.org/10.1038/nature06883">doi:10.1038/nature06883</a>
</p>
<p>Authors: Derek J. Richard, Emma Bolderson, Liza Cubeddu, Ross I. M. Wadsworth, Kienan Savage, Girdhar G. Sharma, Matthew L. Nicolette, Sergie Tsvetanov, Michael J. McIlwraith, Raj K. Pandita, Shunichi Takeda, Ronald T. Hay, Jean Gautier, Stephen C. West, Tanya T. Paull, Tej K. Pandita, Malcolm F. White
&amp; Kum Kum Khanna</p>
<p>Single-strand DNA (ssDNA)-binding proteins (SSBs) are ubiquitous and essential for a wide variety of DNA metabolic processes, including DNA replication, recombination, DNA damage detection and repair. SSBs have multiple roles in binding and sequestering ssDNA, detecting DNA damage, stimulating nucleases, helicases and strand-exchange proteins, activating transcription and mediating protein&#8211;protein interactions. In eukaryotes, the major SSB, replication protein A (RPA), is a heterotrimer. Here we describe a second human SSB (hSSB1), with a domain organization closer to the archaeal SSB than to RPA. Ataxia telangiectasia mutated (ATM) kinase phosphorylates hSSB1 in response to DNA double-strand breaks (DSBs). This phosphorylation event is required for DNA damage-induced stabilization of hSSB1. Upon induction of DNA damage, hSSB1 accumulates in the nucleus and forms distinct foci independent of cell-cycle phase. These foci co-localize with other known repair proteins. In contrast to RPA, hSSB1 does not localize to replication foci in S-phase cells and hSSB1 deficiency does not influence S-phase progression. Depletion of hSSB1 abrogates the cellular response to DSBs, including activation of ATM and phosphorylation of ATM targets after ionizing radiation. Cells deficient in hSSB1 exhibit increased radiosensitivity, defective checkpoint activation and enhanced genomic instability coupled with a diminished capacity for DNA repair. These findings establish that hSSB1 influences diverse endpoints in the cellular DNA damage response.</p>
]]></content:encoded>
<dc:title>Single-stranded DNA-binding protein hSSB1 is critical for genomic stability</dc:title>
<dc:creator>Derek J. Richard</dc:creator>
<dc:creator>Emma Bolderson</dc:creator>
<dc:creator>Liza Cubeddu</dc:creator>
<dc:creator>Ross I. M. Wadsworth</dc:creator>
<dc:creator>Kienan Savage</dc:creator>
<dc:creator>Girdhar G. Sharma</dc:creator>
<dc:creator>Matthew L. Nicolette</dc:creator>
<dc:creator>Sergie Tsvetanov</dc:creator>
<dc:creator>Michael J. McIlwraith</dc:creator>
<dc:creator>Raj K. Pandita</dc:creator>
<dc:creator>Shunichi Takeda</dc:creator>
<dc:creator>Ronald T. Hay</dc:creator>
<dc:creator>Jean Gautier</dc:creator>
<dc:creator>Stephen C. West</dc:creator>
<dc:creator>Tanya T. Paull</dc:creator>
<dc:creator>Tej K. Pandita</dc:creator>
<dc:creator>Malcolm F. White</dc:creator>
<dc:creator>Kum Kum Khanna</dc:creator>
<dc:identifier>doi:10.1038/nature06883</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-04-30</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-04-30</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature06903">
<title>A novel route for ATP acquisition by the remnant mitochondria of Encephalitozoon cuniculi</title>
<link>http://dx.doi.org/10.1038/nature06903</link>
<description>Mitochondria use transport proteins of the eukaryotic mitochondrial carrier family (MCF) to mediate the exchange of diverse substrates, including ATP, with the host cell cytosol. According to classical endosymbiosis theory, insertion of a host-nuclear-encoded MCF transporter into the protomitochondrion was the key step that allowed the host cell to harvest ATP from the enslaved endosymbiont. Notably the genome of the microsporidian Encephalitozoon cuniculi has lost all of its genes for MCF proteins. This raises the question of how the recently discovered microsporidian remnant mitochondrion, called a mitosome, acquires ATP to support protein import and other predicted ATP-dependent activities. The E. cuniculi genome does contain four genes for an unrelated type of nucleotide transporter used by plastids and bacterial intracellular parasites, such as Rickettsia and Chlamydia, to import ATP from the cytosol of their eukaryotic host cells. The inference is that E. cuniculi also uses these proteins to steal ATP from its eukaryotic host to sustain its lifestyle as an obligate intracellular parasite. Here we show that, consistent with this hypothesis, all four E. cuniculi transporters can transport ATP, and three of them are expressed on the surface of the parasite when it is living inside host cells. The fourth transporter co-locates with mitochondrial Hsp70 to the E. cuniculi mitosome. Thus, uniquely among eukaryotes, the traditional relationship between mitochondrion and host has been subverted in E. cuniculi, by reductive evolution and analogous gene replacement. Instead of the mitosome providing the parasite cytosol with ATP, the parasite cytosol now seems to provide ATP for the organelle.</description>
<content:encoded><![CDATA[

<p>
<b>A novel route for ATP acquisition by the remnant mitochondria of Encephalitozoon cuniculi</b>
</p>
<p>Nature advance online publication 30 April 2008. <a href="http://dx.doi.org/10.1038/nature06903">doi:10.1038/nature06903</a>
</p>
<p>Authors: Anastasios D. Tsaousis, Edmund R. S. Kunji, Alina V. Goldberg, John M. Lucocq, Robert P. Hirt
&amp; T. Martin Embley</p>
<p>Mitochondria use transport proteins of the eukaryotic mitochondrial carrier family (MCF) to mediate the exchange of diverse substrates, including ATP, with the host cell cytosol. According to classical endosymbiosis theory, insertion of a host-nuclear-encoded MCF transporter into the protomitochondrion was the key step that allowed the host cell to harvest ATP from the enslaved endosymbiont. Notably the genome of the microsporidian Encephalitozoon cuniculi has lost all of its genes for MCF proteins. This raises the question of how the recently discovered microsporidian remnant mitochondrion, called a mitosome, acquires ATP to support protein import and other predicted ATP-dependent activities. The E. cuniculi genome does contain four genes for an unrelated type of nucleotide transporter used by plastids and bacterial intracellular parasites, such as Rickettsia and Chlamydia, to import ATP from the cytosol of their eukaryotic host cells. The inference is that E. cuniculi also uses these proteins to steal ATP from its eukaryotic host to sustain its lifestyle as an obligate intracellular parasite. Here we show that, consistent with this hypothesis, all four E. cuniculi transporters can transport ATP, and three of them are expressed on the surface of the parasite when it is living inside host cells. The fourth transporter co-locates with mitochondrial Hsp70 to the E. cuniculi mitosome. Thus, uniquely among eukaryotes, the traditional relationship between mitochondrion and host has been subverted in E. cuniculi, by reductive evolution and analogous gene replacement. Instead of the mitosome providing the parasite cytosol with ATP, the parasite cytosol now seems to provide ATP for the organelle.</p>
]]></content:encoded>
<dc:title>A novel route for ATP acquisition by the remnant mitochondria of Encephalitozoon cuniculi</dc:title>
<dc:creator>Anastasios D. Tsaousis</dc:creator>
<dc:creator>Edmund R. S. Kunji</dc:creator>
<dc:creator>Alina V. Goldberg</dc:creator>
<dc:creator>John M. Lucocq</dc:creator>
<dc:creator>Robert P. Hirt</dc:creator>
<dc:creator>T. Martin Embley</dc:creator>
<dc:identifier>doi:10.1038/nature06903</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-04-30</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-04-30</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature06890">
<title>Rapid cloning of high-affinity human monoclonal antibodies against influenza virus</title>
<link>http://dx.doi.org/10.1038/nature06890</link>
<description>Pre-existing neutralizing antibody provides the first line of defence against pathogens in general. For influenza virus, annual vaccinations are given to maintain protective levels of antibody against the currently circulating strains. Here we report that after booster vaccination there was a rapid and robust influenza-specific IgG+ antibody-secreting plasma cell (ASC) response that peaked at approximately day 7 and accounted for up to 6% of peripheral blood B cells. These ASCs could be distinguished from influenza-specific IgG+ memory B cells that peaked 14&#8211;21 days after vaccination and averaged 1% of all B cells. Importantly, as much as 80% of ASCs purified at the peak of the response were influenza specific. This ASC response was characterized by a highly restricted B-cell receptor (BCR) repertoire that in some donors was dominated by only a few B-cell clones. This pauci-clonal response, however, showed extensive intraclonal diversification from accumulated somatic mutations. We used the immunoglobulin variable regions isolated from sorted single ASCs to produce over 50 human monoclonal antibodies (mAbs) that bound to the three influenza vaccine strains with high affinity. This strategy demonstrates that we can generate multiple high-affinity mAbs from humans within a month after vaccination. The panel of influenza-virus-specific human mAbs allowed us to address the issue of original antigenic sin (OAS): the phenomenon where the induced antibody shows higher affinity to a previously encountered influenza virus strain compared with the virus strain present in the vaccine. However, we found that most of the influenza-virus-specific mAbs showed the highest affinity for the current vaccine strain. Thus, OAS does not seem to be a common occurrence in normal, healthy adults receiving influenza vaccination.</description>
<content:encoded><![CDATA[

<p>
<b>Rapid cloning of high-affinity human monoclonal antibodies against influenza virus</b>
</p>
<p>Nature advance online publication 30 April 2008. <a href="http://dx.doi.org/10.1038/nature06890">doi:10.1038/nature06890</a>
</p>
<p>Authors: Jens Wrammert, Kenneth Smith, Joe Miller, William A. Langley, Kenneth Kokko, Christian Larsen, Nai-Ying Zheng, Israel Mays, Lori Garman, Christina Helms, Judith James, Gillian M. Air, J. Donald Capra, Rafi Ahmed
&amp; Patrick C. Wilson</p>
<p>Pre-existing neutralizing antibody provides the first line of defence against pathogens in general. For influenza virus, annual vaccinations are given to maintain protective levels of antibody against the currently circulating strains. Here we report that after booster vaccination there was a rapid and robust influenza-specific IgG+ antibody-secreting plasma cell (ASC) response that peaked at approximately day 7 and accounted for up to 6% of peripheral blood B cells. These ASCs could be distinguished from influenza-specific IgG+ memory B cells that peaked 14&#8211;21 days after vaccination and averaged 1% of all B cells. Importantly, as much as 80% of ASCs purified at the peak of the response were influenza specific. This ASC response was characterized by a highly restricted B-cell receptor (BCR) repertoire that in some donors was dominated by only a few B-cell clones. This pauci-clonal response, however, showed extensive intraclonal diversification from accumulated somatic mutations. We used the immunoglobulin variable regions isolated from sorted single ASCs to produce over 50 human monoclonal antibodies (mAbs) that bound to the three influenza vaccine strains with high affinity. This strategy demonstrates that we can generate multiple high-affinity mAbs from humans within a month after vaccination. The panel of influenza-virus-specific human mAbs allowed us to address the issue of original antigenic sin (OAS): the phenomenon where the induced antibody shows higher affinity to a previously encountered influenza virus strain compared with the virus strain present in the vaccine. However, we found that most of the influenza-virus-specific mAbs showed the highest affinity for the current vaccine strain. Thus, OAS does not seem to be a common occurrence in normal, healthy adults receiving influenza vaccination.</p>
]]></content:encoded>
<dc:title>Rapid cloning of high-affinity human monoclonal antibodies against influenza virus</dc:title>
<dc:creator>Jens Wrammert</dc:creator>
<dc:creator>Kenneth Smith</dc:creator>
<dc:creator>Joe Miller</dc:creator>
<dc:creator>William A. Langley</dc:creator>
<dc:creator>Kenneth Kokko</dc:creator>
<dc:creator>Christian Larsen</dc:creator>
<dc:creator>Nai-Ying Zheng</dc:creator>
<dc:creator>Israel Mays</dc:creator>
<dc:creator>Lori Garman</dc:creator>
<dc:creator>Christina Helms</dc:creator>
<dc:creator>Judith James</dc:creator>
<dc:creator>Gillian M. Air</dc:creator>
<dc:creator>J. Donald Capra</dc:creator>
<dc:creator>Rafi Ahmed</dc:creator>
<dc:creator>Patrick C. Wilson</dc:creator>
<dc:identifier>doi:10.1038/nature06890</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-04-30</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-04-30</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature06875">
<title>HP1-&#946; mobilization promotes chromatin changes that initiate the DNA damage response</title>
<link>http://dx.doi.org/10.1038/nature06875</link>
<description>Minutes after DNA damage, the variant histone H2AX is phosphorylated by protein kinases of the phosphoinositide kinase family, including ATM, ATR or DNA-PK. Phosphorylated (&#947;)-H2AX&#8212;which recruits molecules that sense or signal the presence of DNA breaks, activating the response that leads to repair&#8212;is the earliest known marker of chromosomal DNA breakage. Here we identify a dynamic change in chromatin that promotes H2AX phosphorylation in mammalian cells. DNA breaks swiftly mobilize heterochromatin protein 1 (HP1)-&#946; (also called CBX1), a chromatin factor bound to histone H3 methylated on lysine 9 (H3K9me). Local changes in histone-tail modifications are not apparent. Instead, phosphorylation of HP1-&#946; on amino acid Thr&#8201;51 accompanies mobilization, releasing HP1-&#946; from chromatin by disrupting hydrogen bonds that fold its chromodomain around H3K9me. Inhibition of casein kinase 2 (CK2), an enzyme implicated in DNA damage sensing and repair, suppresses Thr&#8201;51 phosphorylation and HP1-&#946; mobilization in living cells. CK2 inhibition, or a constitutively chromatin-bound HP1-&#946; mutant, diminishes H2AX phosphorylation. Our findings reveal an unrecognized signalling cascade that helps to initiate the DNA damage response, altering chromatin by modifying a histone-code mediator protein, HP1, but not the code itself.</description>
<content:encoded><![CDATA[

<p>
<b>HP1-&#946; mobilization promotes chromatin changes that initiate the DNA damage response</b>
</p>
<p>Nature advance online publication 27 April 2008. <a href="http://dx.doi.org/10.1038/nature06875">doi:10.1038/nature06875</a>
</p>
<p>Authors: Nabieh Ayoub, Anand D. Jeyasekharan, Juan A. Bernal
&amp; Ashok R. Venkitaraman</p>
<p>Minutes after DNA damage, the variant histone H2AX is phosphorylated by protein kinases of the phosphoinositide kinase family, including ATM, ATR or DNA-PK. Phosphorylated (&#947;)-H2AX&#8212;which recruits molecules that sense or signal the presence of DNA breaks, activating the response that leads to repair&#8212;is the earliest known marker of chromosomal DNA breakage. Here we identify a dynamic change in chromatin that promotes H2AX phosphorylation in mammalian cells. DNA breaks swiftly mobilize heterochromatin protein 1 (HP1)-&#946; (also called CBX1), a chromatin factor bound to histone H3 methylated on lysine 9 (H3K9me). Local changes in histone-tail modifications are not apparent. Instead, phosphorylation of HP1-&#946; on amino acid Thr&#8201;51 accompanies mobilization, releasing HP1-&#946; from chromatin by disrupting hydrogen bonds that fold its chromodomain around H3K9me. Inhibition of casein kinase 2 (CK2), an enzyme implicated in DNA damage sensing and repair, suppresses Thr&#8201;51 phosphorylation and HP1-&#946; mobilization in living cells. CK2 inhibition, or a constitutively chromatin-bound HP1-&#946; mutant, diminishes H2AX phosphorylation. Our findings reveal an unrecognized signalling cascade that helps to initiate the DNA damage response, altering chromatin by modifying a histone-code mediator protein, HP1, but not the code itself.</p>
]]></content:encoded>
<dc:title>HP1-&#946; mobilization promotes chromatin changes that initiate the DNA damage response</dc:title>
<dc:creator>Nabieh Ayoub</dc:creator>
<dc:creator>Anand D. Jeyasekharan</dc:creator>
<dc:creator>Juan A. Bernal</dc:creator>
<dc:creator>Ashok R. Venkitaraman</dc:creator>
<dc:identifier>doi:10.1038/nature06875</dc:identifier>
<dc:source>Nature</dc:source>
<dc:date>2008-04-27</dc:date>
<prism:publicationName>Nature</prism:publicationName>
<prism:publicationDate>2008-04-27</prism:publicationDate>
<prism:section>Letter</prism:section>
</item>
<item rdf:about="http://dx.doi.org/10.1038/nature06905">
<title>NF-&#954;B links innate immunity to the hypoxic response through transcriptional regulation of HIF-1&#945;</title>
<link>http://dx.doi.org/10.1038/nature06905</link>
<description>The hypoxic response is an ancient stress response triggered by low ambient oxygen (O2) (ref. 1) and controlled by hypoxia-inducible transcription factor-1 (HIF-1), whose &#945; subunit is rapidly degraded under normoxia but stabilized when O2-dependent prolyl hydroxylases (PHDs) that target its O2-dependent degradation domain are inhibited. Thus, the amount of HIF-1&#945;, which controls genes involved in energy metabolism and angiogen